Products & Services

Back To: Home : This Issue : Products & Services

THIS ISSUE:

Global News

Tools & Technology

Diagnostics

Omics & Systems Biology

Research & Development

Contract Research Services

Products & Services

Commentary

DAILY NEWS:

CONFERENCES AND EXHIBITIONS:

LabAutomation Product Showcase

AACR Product Showcase

SBS Product Showcase

ASMS Product Showcase

DDT Product Showcase

SPECIAL REPORTS:

ddn MARKET RESEARCH:

INDUSTRY CALENDAR:

June 6-7, 2013

European Lab Automation - Hamburg, Germany

June 12-15, 2013

ISSCR 11th Annual Meeting - Boston, Ma

E-NEWSLETTER SUBSCRIPTION:

05-21-2013

Actavis to acquire Warner Chilcott for $8.5 billion

Code: E05221301

05-21-2013

Elan plans more big transactions in wake of billion-dollar Theravance deal

Code: E05221302

05-21-2013

AML genome answers no longer MIA

Code: E05221303

05-21-2013

Researchers uncover role of NOX in development of atherosclerosis in diabetic mice

Code: E05221304

05-21-2013

Novo A/S acquires Xellia Pharmaceuticals for $700 million

Code: E05211301

05-20-2013

Computational model offers insight into mechanisms of drug-coated balloons

Code: E05211302

05-20-2013

AbbVie and Galapagos extend GLPG0634 collaboration to include Crohn's disease

Code: E05171301

05-20-2013

Going public with private news

05-16-2013

Roche, QB3 unite for startups

Code: E05161301

05-15-2013

Almac and University College London team up on metagenomics

Code: E05151302

05-15-2013

AbbVie, Alvine Pharmaceuticals to collaborate on potential celiac disease treatment

Code: E05151301

May 2013

Facing the patent cliff head-on

May 2013

Out of Order: Attention to detail

05-14-2013

Astellas to close down OSI Pharmaceuticals, Perseid Therapeutics

Code: E05141301

05-13-2013

Theravance and Elan enter into a billion-dollar royalty participation deal

Code: E05131301

05-13-2013

Cocaine vaccine a step closer to human trials

Code: E05101301

05-09-2013

Merck, GSK make commitments to GAVI Alliance to provide discounted HPV vaccines

Code: E05091301

05-08-2013

Takeda acquires Inviragen for $35 million up front

Code: E05081300

05-07-2013

Concert in tune with Celgene for $300 million deal

Code: E05081301

05-07-2013

$112 million ADC collaboration marks third Bristol-Myers Squibb/Ambrx deal in two years

Code: E05081302

05-07-2013

Taking a LOAD off your mind

Code: E05081303

May 2013

The many colors of sequestration

May 2013

ISSCR 2013 Show Preview: From stem to stern

Code: E051328

May 2013

ISSCR 2013 Show Preview (continued)

May 2013

From lab to clinic in the Sunshine State

Code: E051318

May 2013

Soaking up some UVP rays

Code: E051317

May 2013

Code: E051319

May 2013

Partners in search of a prognosis

Code: E051320

May 2013

New Alzheimer’s rat model will boost research

May 2013

KineMed renews diabetes collaboration with Pfizer

May 2013

Proteros, Priaxon to collaborate on PPIs

May 2013

Developing answers for developing nations

Code: E051305

May 2013

A partnership with some pep(tides)

Code: E051306

May 2013

Getting personal about profiling

Code: E051307

May 2013

Coordinated TAKTIC

Code: E051308

May 2013

Capital alliance formed to discuss iPS collaboration

May 2013

Debiopharm, Shasun announce licensing deal

May 2013

New partners ink China-based deal

May 2013

Life for Thermo

Code: E051301

May 2013

‘2013: A bad year to have a good idea’

Code: E051302

May 2013

Straight A's with ADCs

Code: E051303

May 2013

Two ways to look at it

Code: E051304

May 2013

All about antibodies

Code: E051313

May 2013

A firm foundation for Agios

Code: E051314

May 2013

The power of prediction

Code: E051315

May 2013

To cancer and beyond

Code: E051316

May 2013

FDA releases MDx draft guidance

May 2013

Biodesix, Bruker launch agreement to support lung cancer test

May 2013

Insight Genetics selected for NCI’s Clinical Assay Development Program

May 2013

Patent Docs: Supreme Court’s consideration of IP rights exhaustion impacts pharma, biotech industries

May 2013

Half a loaf, maybe

Code: E051325

May 2013

States beg to differ on biosimilar concerns

Code: E051326

May 2013

Next-gen data dynamic duo

Code: E051310

May 2013

TAPs for Thermo Fisher

Code: E051311

May 2013

Gaining ground with genomics

Code: E051312

May 2013

Core Informatics and OpenEye Scientific Software forge partnership

May 2013

Rockland Immunochemicals acquires antibody line from 21st Century Biochemicals

May 2013

Accelrys, eMolecules ink collaboration

May 2013

Abcam signs license agreement with Columbia

May 2013

Nanomedicine: The next (not-so-) big thing

Code: E051321

May 2013

MedImmune makes a move

Code: E051322

May 2013

A pair of model-building aficionados

Code: E051323

May 2013

New hope for a cruel disease

Code: E051324

May 2013

Ergomed joins Aeterna Zentaris for Phase III cancer trial

May 2013

Cyclica collaborates with Dalton Pharma Services

May 2013

Inventiva, NovAliX establish strategic alliance

05-07-2013

UC Riverside researchers identify key cellular organelle involved in gene silencing

Code: E050801

05-07-2013

Astellas, Drais to form virtual company

Code: E05071301

05-06-2013

Prostate cancer survey indicates strong uptake with regard to new hormone-based agents

Code: E05061301

05-06-2013

Regeneron expands ophthalmology portfolio by acquiring rights to Sanofi development programs

Code: E05031301

05-02-2013

Foundation Medicine, Memorial Sloan-Kettering partner on hematologic cancer test

Code: E05021301

05-01-2013

QIAGEN bolsters its database offerings with Ingenuity acquisition

Code: E04301301

05-01-2013

Real Time Genomics, J. Craig Venter Institute announce collaborations

Code: E05011301

04-29-2013

FORMA Therapeutics forges $200 million deal with Celgene

Code: E04291301

04-29-2013

Theravance to split in two

Code: E04261301

04-25-2013

OPKO, PROLOR sign definitive merger agreement

Code: E04241301

04-25-2013

Research institutions, hospitals announce London Lung Cancer Initiative

Code: E04251301

04-23-2013

Refining the aim in the hunt for tumor cells

Code: E04241301

04-23-2013

OHSU teams with Intel to decode root causes of cancer and other complex diseases

Code: E04241302

04-23-2013

UA researchers identify possible cause of statin side effects in cholesterol patients

Code: E04241303

04-23-2013

Minding methylation

Code: E04241304

04-23-2013

GSK, Avalon Ventures announce $495 million startup deal

Code: E04231301

04-22-2013

A rallying point for cancer research

Code: E04221302

04-22-2013

Merck and Bristol-Myers Squibb to jointly study potential hepatitis C therapy

Code: E04221301

04-21-2013

Cerecor gains rights to potential depression treatment from Merck

Code: E04191301

04-18-2013

Lilly acquires PET tracers for Alzheimer's imaging

Code: E04171301

04-18-2013

Myriad announces commercial agreement with RainDance Technologies

Code: E04181301

04-16-2013

Bristol-Myers Squibb teams up with Santaris Pharma

Code: E04161301

04-15-2013

Thermo Fisher Scientific to acquire Life Technologies for more than $13 billion

Code: E04151301

04-12-2013

Mobidiag, Genewave and Amplidiag merge to become leading innovator in molecular diagnostics

Code: 04121301

04-11-2013

Quest Diagnostics, Matrix-Bio announce licensing agreement

Code: E04111301

04-10-2013

NCI, CvergenX to partner on radiosensitivity assay

Code: E04101301

04-09-2013

Roche and Isis Pharmaceuticals form $392 million alliance against Huntington's disease

Code: E04101301

04-09-2013

Stopping RA before it starts

Code: E04101302

04-09-2013

Sanford-Burnham researchers unravel molecular roots of Down syndrome

Code: E04101303

04-09-2013

Straightening out serotonin receptors

Code: E04101304

04-09-2013

Anacor inks agreement with Gates Foundation

Code: E04091301

04-08-2013

Resverlogix Corp. to spin out RVX Therapeutics Inc.

Code: E04051301

04-08-2013

Astellas and Ambrx sign $300 million ADC oncology deal

Code: E04051301

April 2013

BIO 2013 show preview: Twenty years strong

Code: E041304

April 2013

The new apple of Shire’s eye

Code: E041306

April 2013

Six biosimilars for 70 emerging markets

Code: E041307

April 2013

BIO 2013: Additonal coverage of the show, BIO news and more photos

April 2013

Top 3 reasons the Supreme Court is sure to be a hot topic at BIO 2013

April 2013

SPECIAL REPORT: An aside on side effects

Code: E041305

April 2013

Takeda and Resolve pair up on autoimmunity

Code: E041308

April 2013

RAR-alpha for AD

Code: E041309

April 2013

Roche, Galapagos end alliance

April 2013

OPKO completes Latin American acquisition

April 2013

Riboxx, CNBG unite in collaboration

April 2013

HD biomarkers in CSF

Code: E041318

April 2013

Clean and mean cells

Code: E041319

April 2013

Gaining ground with GPCRs

Code: E041320

April 2013

Four-stranded anticancer DNA

Code: E041321

April 2013

Broad Institute selects Convey Computer system for data analysis

April 2013

PGDx inks genome mapping license deal with Johns Hopkins

April 2013

OGT, CCMC announce license agreement

April 2013

SynapDx Corp., Illumina join hands

Code: E041314

April 2013

FISHing for success

Code: E041315

April 2013

Order out of chaos

Code: E041316

April 2013

Lab21, IntegraGen team up for colorectal CDx

April 2013

BioChain licenses Septin9 marker from Epigenomics

April 2013

Ventana, Biocare ink agreement for p63 technology

April 2013

CROs with global aspirations

Code: E041326

April 2013

A powerful injection

Code: E041301

April 2013

Developing a solid BACE

Code: E041302

April 2013

Natural neighbors

Code: E041303

April 2013

Revolutionizing and personalizing global health

April 2013

East meets West Coast

Code: E041327

April 2013

Covance, M2Gen play matchmaker

Code: E041328

April 2013

Keeping up is hard to do

April 2013

The best of both worlds

Code: E041329

April 2013

Accelovance acquires Radiant Development

April 2013

Neuland Labs, APIC sign manufacturing collaboration

April 2013

Pharma industry pow-wows: Waiting on the smoke signal

April 2013

QPS, The Hamner launch QPS Hepatic Biosciences

April 2013

In like a laminin, out like a lion

Code: E041310

April 2013

Driving stem cells to the clinic

Code: E041311

April 2013

NEP explores the exosome

Code: E041312

April 2013

A new PREMIER tool

Code: E041313

April 2013

Affymetrix allies with GenoSplice

April 2013

BioReliance acquires Big Blue assay colonies from Sigma-Aldrich

April 2013

Covaris, HORIBA Instruments ink marketing alliance

April 2013

High-profile oncology partnership

Code: E041322

April 2013

Sick and tired of being sick and tired

Code: E041323

April 2013

Bonded by blood

Code: E041324

April 2013

In-vivo investigators

Code: E041325

April 2013

Valeant acquires U.S. Targretin rights from Eisai

April 2013

Sanford-Burnham, Mayo join forces

April 2013

Lonza awarded second NIH iPSC contract

April 2013

FEATURED PRODUCT: Mitochondrial evaluation assays

April 2013

Flexible, open platform

April 2013

Non-invasive near infrared imaging agent

April 2013

Particle analyzers for nanoparticles

April 2013

LNA gapmers for mRNA, lncRNA inhibition studies

April 2013

Next-generation data analysis software

April 2013

Flexible PCR setup workstation

April 2013

DMSO verification solution

April 2013

hERG channel screenings

April 2013

Multiplex genomic reference standard

April 2013

High-resolution microscopy plate

April 2013

Monoclonal antibodies against fluorescent proteins

April 2013

Sensitive, flexible detection platform

April 2013

Short PCR run times

April 2013

Automated DNA sample enrichment

04-04-2013

CollabRx teams up with OncoDNA

Code: E04041301

04-03-2013

BIND Therapeutics, Pfizer announce global collaboration

Code: E04031301

04-02-2013

Merz Pharma announces $383.5 million proposal for Obagi

Code: E04021301

04-01-2013

ArQule regains rights to AKT compounds from Daiichi Sankyo

Code: E04011301

03-31-2013

Quartette approval represents next generation in women's contraceptives, says Teva

Code: E03291301

03-28-2013

Lundbeck to collaborate with Otsuka Pharmaceutical for Alzheimer's drug candidate

Code: E03271301

03-28-2013

Edison, DSP announce R&D agreement

Code: E03281301

03-26-2013

Shire sees value in SARcode

Code: E03271301

03-26-2013

National Brain Tumor Society announces launch of the Defeat GBM Research Collaborative

Code: E03271302

03-26-2013

Third Rock Ventures stocks up with $516 million new fund

Code: E03271303

03-26-2013

Trio of research teams discover potential link between salt, genetic factors in autoimmune disease

Code: E03271304

03-26-2013

Taking down Down syndrome

Code: E03271305

03-26-2013

INDIGO’s new MitoVir platform provides novel approach to evaluating mitochondrial toxicity

Code: E03271306

03-24-2013

Xceleron and JCL Bioassay announce partnership in early clinical investigations

Code: E03221301

03-22-2013

BGI, H3 initiate cancer data partnership

Code: E03211301

03-20-2013

Valeant acquires Obagi Medical Products

Code: E03201301

03-19-2013

Wellcome Trust Sanger, Mass. General, Blueprint to collaborate on cancer targets

Code: E03191301

03-18-2013

ChromoTek licenses Chromobody technology for high-content drug profiling to Bayer

Code: E03181301

03-17-2013

Novartis lung cancer drug earns breakthrough therapy designation from FDA

Code: E03151301

03-15-2013

Receptos links up with AbbVie to develop potential orphan disease drug

Code: E03141301

03-14-2013

Merck, Luminex to develop AD companion diagnostic device

Code: E03131300

03-13-2013

Shire enters neonatology field with Premacure acquisition

Code: E03121301

03-12-2013

EU launches $12 million project to scour the deep seas for bioactive compounds

Code: E03131301

03-12-2013

Ajinomoto agrees to acquire Althea Technologies for about $175 million

Code: E03131302

03-12-2013

UC Davis researchers probe microglia’s role in developing brain

Code: E03131303

03-12-2013

Working with a master

Code: E03131304

March 2013

A capitol idea -- AACR 2013 conference preview

Code: E031304

March 2013

A capitol idea -- AACR 2013 conference preview (Part 2)

March 2013

MAP leads to pot of gold

Code: E031322

March 2013

Marriage for MS treatment

Code: E031323

March 2013

Canada continues stem cell tradition

Code: E031324

March 2013

Maxing out with GVAX

Code: E031325

March 2013

Sun Pharma, Taro scrap merger

March 2013

NCI announces new SBIR funding opportunity

March 2013

Leica Biosystems seeks growth in Mass.

March 2013

End-to-end workflow

Code: E031310

March 2013

Dealing with the data

Code: E031311

March 2013

A P4 partnership

Code: E031312

March 2013

Adding new dimensions

Code: E031313

March 2013

Thermo Fisher Scientific partners with Barnett Institute on LC-MS advancement

March 2013

Trinean secures Caliper license for UV/VIS technology

March 2013

LabSmith, Fluigent ink microfluidics partnership

March 2013

Heart-smart commercialization

Code: E031318

March 2013

It’s only logical

Code: E031319

March 2013

Drawing a better map

Code: E031320

March 2013

Glycomics on the map

Code: E031321

March 2013

Institute for Precision Medicine opens its doors

March 2013

Salk Institute receives $42 million for new genomic center

March 2013

Mayo Clinic, SV Bio unite for genome diagnostics

March 2013

The USPTO uncertainty principle

Code: E031326

March 2013

FDA on a hot streak

Code: E031327

March 2013

Taking it to the states

Code: E031328

March 2013

Addressing a growing need

Code: E031306

March 2013

European Lead Factory launched

Code: E031307

March 2013

Resistance really is futile

Code: E031308

March 2013

Uber-antibiotic duo

Code: E031309

March 2013

Teva terminates monoclonal antibody deal with CureTech

March 2013

Dyax, CVie announce Eastern angioedema partnership

March 2013

BioFocus, ChanTest ink agreement

March 2013

A deeper companionship

Code: E031314

March 2013

When East meets West

Code: E031315

March 2013

Code: E031317

March 2013

Clarient adopts QIAGEN’s KRAS CDx

March 2013

JPT Peptide, Institute for Medical Immunology partner on chronic fatigue syndrome

March 2013

Companies to trade access to IP for T cell-based assays

March 2013

Carmenta Bioscience secures Dx license from Stanford

03-11-2013

Cubist obtains remaining rights for ceftolozane from Astellas

Code: E03011301

03-11-2013

Biovest seeks bankruptcy protection for restructuring

Code: E03081301

March 2013

A breakup worth billons

Code: E031301

March 2013

Safer drugs, better cancer care

Code: E031302

March 2013

Meddling with medulloblastoma

Code: E031303

March 2013

A genome’s got to know its limitations

March 2013

Out of Order: Didn’t see that coming

March 2013

Cancer patients: The heart of the matter

March 2013

‘Good enough’ is no longer good enough

Code: E031305

March 2013

Low-input DNA, RNA library prep

March 2013

Fast, simple 96- and 384-well pipetting

March 2013

Patient-derived xenograft models

March 2013

Live-cell RNA detection

March 2013

Tumor cell panels

March 2013

RNA FISH probes

March 2013

Cryogenic storage labels

March 2013

Centrifugal affinity purification

March 2013

Automated workstation for increased sample throughput

March 2013

Reagents for streamlined DNA prep workflows

March 2013

Protein contaminant detection

March 2013

HCP antibody evaluation workflow

March 2013

Integrated LC/MS platform

March 2013

SPR-based biomolecular interaction analysis techniques

March 2013

DNA sequencing kits

March 2013

NGS workflow for clinical research, diagnostics

March 2013

Expanded mobile measurement portfolio

03-07-2013

MRC Technology, MS Society call for MS targets

Code: E03061301

03-07-2013

Agilent joins Applied Proteomics in mass spec deal

Code: E03071301

03-06-2013

Life Technologies links up with Harvard in stem cell deal

Code: E03051301

03-05-2013

Elan introduces new cash dividend policy for shareholders

Code: E03041301

03-03-2013

Capsugel acquires Encap Drug Delivery

Code: E03011301

02-28-2013

Jazz, Concert Pharmaceuticals make music with license agreement

Code: E02271300

02-28-2013

Mylan to acquire Agila Specialties

Code: E02281301

02-26-2013

Elan Corp. to buy back $1 billion of stock after Tysabri sale

Code: E02271301

02-26-2013

LEO Pharma and 4SC Discovery form pact worth as much as $125 million

Code: E02271302

02-26-2013

Mount Sinai lab uncovers epigenetic activity in depression

Code: E02271303

02-26-2013

Patching up vaccine issues

Code: E02271304

02-26-2013

Royalty Pharma proposes to acquire Elan, gets cold shoulder instead

Code: E02261301

02-25-2013

Ticket to ride for nanos

Code: E02221301

02-25-2013

FDA grants fast-track designation for MediciNova's compound to treat meth dependence

Code: E02251301

02-21-2013

Abbott, Janssen, Pharmacyclics to collaborate on leukemia CDx

Code: E02211301

02-20-2013

Cepheid, Knight Cancer Institute embark on collaboration

Code: E02201301

02-19-2013

QIAGEN joins WaferGen in co-marketing agreement

Code: E02191301

02-18-2013

Optibrium and Lhasa seek to bring better toxicity prediction to chemists’ desktops

Code: E02151301

02-14-2013

Pantarhei Bioscience sells estrogen therapy to Uteron Pharma

Code: E02131300

02-14-2013

QIAGEN, Lilly to develop companion diagnostics

Code: E02141301

02-13-2013

Novozymes, EpiVax join forces

Code: E02121301

02-12-2013

Improving aim against tumors with Accurins

Code: E02131301

02-12-2013

FDA approves Celgene's multiple myeloma drug

Code: E02131302

02-12-2013

Better delivery through compression

Code: E02131303

02-12-2013

TSRI chemists unveil new technique for marking and selecting cells

Code: E02131304

02-11-2013

Perrigo acquires Rosemont Pharmaceuticals for $283 million

Code: 02111301

02-11-2013

Taro and Sun terminate merger plans

Code: E02081301

February 2013

SOT 2013 Annual Meeting and ToxExpo: One-stop toxicology shop (Part 2)

February 2013

The times, they are a changin’ in the biopharma market

February 2013

That’s not fair! Or is it?

February 2013

Sherley v. Sebelius: Where do we go from here?

February 2013

Lilly, Dako make powerful companions

Code: E021312

February 2013

CDx deal is thrice as nice

Code: E021313

February 2013

QIAGEN plus four

Code: E021314

February 2013

Passing the transplantation diagnostics torch

Code: E021315

February 2013

Life Tech, Boston Children’s Hospital launch clinical genomics company

February 2013

Lab21 divests S.C. operations

February 2013

Verastem selects LabCorp for CDx partner

February 2013

SeraCare sells biorepository business to Precision Health Holdings

February 2013

Shire acquires Lotus Tissue Repair, gains potential therapy for rare skin disease

Code: E021316

February 2013

My antisense is tingling

Code: E021317

February 2013

From platform to clinic

Code: E021318

February 2013

Autism spectrum under study

Code: E021319

February 2013

MD Anderson, Trovagene to study transrenal BRAF mutations in primary, metastatic cancers

February 2013

Evotec, Apeiron ink cancer immunotherapy agreement

February 2013

Weill Cornell’s Tres Cantos project targets TB

February 2013

Sigma donates RNA libraries to the RNA Institute

February 2013

Sutro-Celgene partnership a strategic fit

Code: E021320

February 2013

A LEAP forward for stem cell research

Code: E021322

February 2013

Stem cell developers Give Cures

Code: E021323

February 2013

Sanofi Pasteur, Sutro Biopharma collaborate on vaccine production

February 2013

BioMarin acquires Zacharon Pharmaceuticals

February 2013

Neuroscience focus of AstraZeneca, Vanderbilt deal

February 2013

MacroGenics, Gilead pair up on DART project

02-07-2013

European drug discovery initiative launched among academia, industry

Code: E02071301

February 2013

SOT 2013 Annual Meeting and ToxExpo: One-stop toxicology shop (Part 1)

Code: E021328

February 2013

Market share for Bio-Rad; focused direction for MorphoSys

Code: E021308

February 2013

124 and counting

Code: E021309

February 2013

Shifting from manual to automatic

Code: E021310

February 2013

Alliance of a lifetime

Code: E021311

February 2013

Lonza partners with Sartorius Stedim Biotech on cell culture media

February 2013

Bruker teams with Erasmus Medical Center

February 2013

Titian, Labcyte unite technology

February 2013

Hamilton breaks ground on new facility

February 2013

End of the road for hESC opponents

Code: E021301

February 2013

Getting under our skin

Code: E021302

February 2013

Looking for a prenatal payoff

Code: E021303

February 2013

Controlling the flow of information

Code: E021324

February 2013

A deal with 'significant efficiencies'

Code: E021325

February 2013

Second time around

Code: E021326

February 2013

Not your usual CRO arrangement

Code: E021327

February 2013

Questcor Pharmaceuticals acquires BioVectra

February 2013

Synteract acquires Harrison Clinical Research

February 2013

CHOP, BGI target pediatric diseases

February 2013

Catalent targets biosimilars with UMN Pharma

February 2013

Improving immune response

Code: E021304

February 2013

Trio tackles translational research

Code: E021305

February 2013

Getting AMP-ed up

Code: E021306

February 2013

Aligned in oncology

Code: E021307

February 2013

GSK, GlycoVaxyn in bacterial vaccine collaboration

February 2013

ARIAD, NCRI collaborate on Phase III leukemia study

February 2013

CEVEC, Yuhan ink license agreement

February 2013

Oxford Nanopore completes series of collaborations

February 2013

Flexible open platform

February 2013

Purified DNA, cDNA offerings

February 2013

Fully automated blood fractionation

February 2013

High-pressure ion chromatography system

February 2013

Versatile image analysis system

February 2013

Flexible microplate storage

February 2013

Rapid multiplexed imaging

February 2013

Metabolic biomarker kits

February 2013

Fast, simple 96- and 384-channel pipetting

February 2013

Automated pipetting systems

February 2013

Small-diameter UHPLC media

February 2013

Washer performance testing

February 2013

Single-platform phenotypic screening

February 2013

Blue light LED illuminators

February 2013

Modular flow reactor systems

February 2013

Walk-away tube and vial labeling

February 2013

Enhanced recombinant Factor C assay

February 2013

Automated buffy coat isolation

02-06-2013

Biogen Idec purchases TYSABRI interest from Elan

Code: E02061301

02-05-2013

Merck Serono, Opexa Therapeutics team up for MS therapy

Code: E02051301

02-04-2013

The Medicines Company and Alnylam form strategic alliance

Code: E02041301

02-03-2013

Scripps Research Institute confirms critical role for microRNAs in development of memory

Code: E02011301

01-31-2013

Weill Cornell, NewYork-Presbyterian establish the Institute for Precision Medicine

Code: E01311301

01-30-2013

Life Technologies spearheads influenza initiative

Code: E01291301

01-30-2013

BioClinica, CoreLab Partners to be acquired, merged

Code: E01301301

01-28-2013

Novartis quells speculation about selling Roche share; AstraZeneca picks up where J&J left off

Code: E01251301

01-24-2013

Allergan to acquire MAP Pharmaceuticals for $958 million

Code: E01231301

01-24-2013

Baxter acquires hemophilia A assets from Inspiration, Ipsen

Code: E01241301

01-22-2013

Life Technologies might be on the market

Code: E01231301

01-22-2013

A ‘crucial' partnership

Code: E01231202

01-22-2013

A CRISPR method for genome editing

Code: E01231303

01-22-2013

Multitasking with MALT1

Code: E01231304

01-22-2013

SV Bio, Mayo Clinic join forces

Code: E01221300

01-21-2013

Botox receives yet another indication, this time for overactive bladder

Code: E01211301

01-17-2013

PsiOxus Therapeutics lands $3.3 million DTRA contract

Code: E01161301

01-17-2013

CNGB-Shenzhen, NMNH announce biorepository agreement

Code: E01171301

01-15-2013

Vanderbilt, AstraZeneca partner on neurological candidates

Code: E01151301

01-14-2013

Second tranche for Aileron brings total round to $42 million

Code: E01141301

01-14-2013

MIND Institute researchers receive grants from Autism Speaks

Code: E01111301

January 2013

Catching something in China

Code: E011312

January 2013

The sooner the diagnosis, the better the outcome

Code: E011313

January 2013

Highly personalized medicine

Code: E011314

January 2013

PROOF for FFPE samples

Code: E011315

January 2013

SynapDx secures $6 million to advance autism test

January 2013

Thermo Fisher sepsis test focus of Fujirebio license agreement

January 2013

Invivoscribe granted mutation detection license from Takara Bio

January 2013

ImaginAb secures Oxford BioMedica license for 5T4-based diagnostic

January 2013

Consortium of binding interactions

Code: E011304

January 2013

QC for Alzheimer’s disease

Code: E011305

January 2013

Combating cancer across the pond

Code: E011306

January 2013

Taking it to the tumors

Code: E011307

January 2013

Activiomics signs research agreement with Kyowa Hakko Kirin

January 2013

AstraZeneca, Optimer Pharma target C. diff in South America

January 2013

Lilly, Strides Arcolab in emerging markets collaboration

January 2013

MorphoSys, Lanthio Pharma ink tech allianceMorphoSys, Lanthio Pharma ink tech alliance

January 2013

Second Circuit Court of Appeals rules on Caronia

Code: E011324

January 2013

Will FDA ‘reboot’ antibiotic approval process?

Code: E011325

01-10-2013

Shire expands orphan disease repertoire with Lotus acquisition

Code: E01091301

January 2013

A game-changer in toxicity testing

Code: E0111316

January 2013

Tens, not thousands

Code: E011317

January 2013

A ‘crucial’ partnership

Code: E011318

January 2013

Different genetic fingerprint

Code: E011319

January 2013

DNA2.0 partners with Newcastle U on B. subtillis system

January 2013

Marina Biotech licenses UNA technology to Tekmira

January 2013

uniQure, Benitec ink cross-licensing RNAi agreement

January 2013

Quartet of ICGC projects launched in China

January 2013

Duet with ALK and FISH

Code: E011308

January 2013

Getting predictive with bioisosteres

Code: E011309

January 2013

Getting PRO-ACTive about ALS

Code: E011310

January 2013

A new connection with Genection

Code: E011311

January 2013

Rockland Immunochemicals acquires eBioscience product line

January 2013

Cisbio, BellBrook ink distribution agreement

January 2013

LC-MS focus of McKinley Scientific-New Objective co-marketing deal

January 2013

Portugal joins life-science initiative

January 2013

New CoMMpass bearings

Code: E011320

January 2013

Secondhand stem cell sale

Code: E011321

January 2013

What was old is new again

Code: E011322

January 2013

For the love of a child

Code: E011323

January 2013

Sarepta Therapeutics, UCL partner on DMD drug target

January 2013

Genisphere, LIMR partner on nanotherapeutics

January 2013

Two companies join Florida life-science community

January 2013

Parabon receives NSF grant for prostate cancer therapeutic

January 2013

Biofluid microRNA extraction

January 2013

Updated emulation technology

January 2013

Cell compartment analysis at nanometer scale

January 2013

96-well plates for 3D cell-based assays

January 2013

Guided pipetting system

January 2013

Fast, low-input DNA, RNA library prep

January 2013

Compact, automated biobanking systems

January 2013

PCR system performance validation

January 2013

High clarification prefilters

January 2013

Sterile, cell-repellent culture vessels

January 2013

Low-level dispensation

January 2013

Cost-effective assay solution

January 2013

Increased cell culture productivity

January 2013

High-throughput miniaturization

January 2013

1D cell migration plates

January 2013

Fast and sensitive high-content cell imaging

01-09-2013

Sherley v. Sebelius put to bed

Code: E01081301

01-08-2013

A new connection with Genection

Code: 01091301

01-08-2013

Amgen and BIND enter into roughly $180 million nanomedicine deal

Code: 01091302

01-08-2013

Hope for heart patients may be gene therapy away

Code: 01091303

01-08-2013

Amplifying the signal

Code: 01091304

January 2013

No vaccine is an island

Code: E011326

01-07-2013

Illumina agrees to acquire Verinata Health

Code: E01071301

01-07-2013

Cellular Dynamics stikes agreement with AstraZeneca to use iPSC-derived human cells in drug discovery research

Code: E01041301

January 2013

The need for improved half-life extension technologies

January 2013

Out of Order: Out of the Mayan pan

January 2013

Three resolutions to improve your business in ‘13

January 2013

Coming around again with gene patents

Code: E011301

January 2013

Selecta, Sanofi partnership nothing to sneeze at

Code: E011302

January 2013

Making trials less of a trial

Code: E011303

January 2013

Consortium of binding interactions

Code: E011304

01-03-2013

Squaring off against SMA

Code: E01031301

01-02-2013

AbbVie born from Abbott's separated pharmaceuticals business

Code: E01021301

12-28-2012

Perrigo acquires remaining stake in Cobrek Pharmaceuticals for approximately $45 million

Code: E12281201

12-28-2012

Takeda and Amylin terminate $1 billion anti-obesity pact

Code: E12271201

12-21-2012

Reckitt Benckiser completes tender offer for Schiff Nutrition

Code: E12201201

12-19-2012

OpGen partners with UC Davis in 100K Genome Project

Code: E12191201

12-18-2012

GE Healthcare Life Sciences, CDI announce license agreement

Code: E12181201

12-17-2012

Vivalis to acquire and merge with Intercell for $174 million

Code: E12171202

12-17-2012

Titan Pharmaceuticals and Braeburn Pharmaceuticals sign license agreement worth up to $305 million

Code: E12171201

12-13-2012

Gilead nabs YM BioSciences for $510 million

Code: E12121200

12-13-2012

Registries for All Diseases named Sanofi US' Collaborate Activate Innovation Challenge winner

Code: E12131201

December 2012

Trio of lymphoma panels

December 2012

Intuitive liquid handling

December 2012

Image acquisition and analysis software

December 2012

Best-in-class thermal cyclers

December 2012

Automated liquid handling platform

December 2012

Automated online sample preparation for UPLC

December 2012

Advanced liquid handling, sample-prep automation

December 2012

Accurate biomarker quantification

December 2012

Compact, high-precision microplate washer

December 2012

Cell analyzer for high-throughput applications

December 2012

Universally compatible NGS consumables

December 2012

ELISA for reproducibility, low cross-reactivity

December 2012

Plasma stability upgrade

December 2012

High-performance cell lines

December 2012

Micro-volume protein stability analysis

12-12-2012

ADA kicks off multiyear diabetes initiative

Code: E12111201

12-11-2012

Biogen Idec and Isis Pharmaceuticals enter drug development pact worth as much as $630 million

Code: E12121201

12-11-2012

Code: E12121202

12-11-2012

Mount Sinai researchers probe ‘junk DNA’ for neurological clues

Code: E12121203

December 2012

Forest, Adamas announce licensing agreement for dementia therapy

December 2012

Lots of attention for ADHD

Code: E121201

December 2012

bacTRAP, do it again

Code: E121202

December 2012

Code: E121203

December 2012

Room for IMPROVER

Code: E121204

December 2012

A reflection on the old and in with the new

December 2012

I’ve fallen … and I can’t get up!

December 2012

An alternative view of drug-like properties

12-11-2012

OpenGate acquires Lab Workstations from Thermo Fisher Scientific

Code: E121209

December 2012

Life Tech acquires Advanced Microscopy Group

Code: E121210

December 2012

Hide and BioSeek

Code: E121210

December 2012

Bottom-up ‘omics integration

Code: E121212

December 2012

Wake Forest University and NanoMedica awarded grants to advance ‘Google search for new drugs’

December 2012

Bio-Rad acquires Propel Labs’ cell-sorting system

December 2012

Hamilton, GE Healthcare reveal new workstation

December 2012

Rockland expands LIMR licensing relationship

December 2012

SLAS2013 preview: Inside inspiration (part 1)

Code: E121229

December 2012

Amgen, KPCB create new spinout biotech firm

Code: E121218

December 2012

Neurodegeneration dream team

Code: E121222

December 2012

Give me a ‘C’

Code: E121223

December 2012

Macrocycles by the millions

Code: E1211224

December 2012

SLAS2013 preview: Inside inspiration (part 2)

December 2012

UIC team develops new Alzheimer’s mouse model

December 2012

Synthetic Biologics acquires C. diff assets from Prev AbR

December 2012

Partnership to develop cell lines, reagents for iPS cell research

December 2012

Where two Rivers meet

Code: E121225

December 2012

Code: E121226

December 2012

Anticancer stem cell therapeutics

Code: E121227

December 2012

Fujifilm, Piramal simplify complexities

Code: E121228

December 2012

Oxygen Biotherapeutics engages PPD to execute trial for brain injury therapy

December 2012

GE Capital announces Syngene investment

December 2012

Pfizer, Cyprotex ink research agreement

December 2012

Cytovance awarded Fountain BioPharma contract

December 2012

IRIS opens on diagnostics

Code: E121213

December 2012

Code: E121214

December 2012

Gaining ground on multiple sclerosis

Code: E121215

December 2012

Marked for survival

Code: E121216

December 2012

Courtagen, Alliance Global to distribute MDx tests

December 2012

Ingenuity Systems, LabCorp to develop bioinformatics tools

December 2012

A multinational merger

Code: E121205

December 2012

OPKO Health receives Gates Foundation grant

December 2012

Advanced Cell Diagnostics completes Series B financing round

December 2012

Trio is together again

Code: E121206

December 2012

A harmonious position

Code: E121207

December 2012

OBT, easy as ADC

Code: E121208

December 2012

TPP Global, Sprint Biosciences in cancer therapeutics deal

December 2012

Cambridge U researchers form U.K. stem cell supply company

December 2012

iPS cell initiative unites U.K. researchers

December 2012

AET BioTech, BioXpress partner on biosimilar

December 2012

Paving the way to personalized medicine

Code: E121217

December 2012

Tennessee titans (of healthcare)

Code: E121218

December 2012

GENESIS of gene editing

Code: E121223

December 2012

An ‘almost perfect match’

Code: E121220

December 2012

Multinational research team finds gene variant in Alzheimer’s disease

December 2012

Trio to develop multiple myeloma model

December 2012

EMD Millipore, Sistemic partner on stem cell processing

December 2012

New England Biolabs receives SBIR grant

12-10-2012

Amgen to acquire deCODE genetics for $415 million

Code: E12101201

12-10-2012

GSK and MD Anderson enter into cancer immune therapy deal potentially worth more than $335 million

Code: E12071201

12-07-2012

Academia, industry join in massive iPS partnership

Code: E12061201

12-05-2012

DELSIA, Seaside Therapeutics announce biomarker partnership

Code: E12041201

12-05-2012

Baxter to acquire Gambro AB

Code: E12051201

12-03-2012

Optimer Pharmaceuticals and AstraZeneca strike $23 million deal for C. difficile drug

Code: E12031201

12-03-2012

BioCryst and Presidio call off planned merger

Code: E11301201

11-29-2012

Selecta signs with Sanofi

Code: E11281200

11-29-2012

Smith & Nephew to acquire Healthpoint Biotherapeutics

Code: E11291201

11-27-2012

Big investment in developing markets, a new joint venture and a business on the block

Code: E11281201

11-27-2012

BASF makes roughly $850 million takeover bid for Pronova BioPharma

Code: E11281202

11-27-2012

Scripps Florida scientists reveal key protein interactions involved in neurodegenerative disease

Code: E11281203

11-27-2012

Triggering T cells

Code: E11281204

11-27-2012

Complete Genomics continues to spurn Illumina offer

Code: E11271201

11-21-2012

Pfizer, CFFT expand cystic fibrosis collaboration

Code: E11201201

11-19-2012

Illumina admits it’s the mystery company that made unsolicited bid for Complete Genomics

Code: E11191201

11-19-2012

Allergan to acquire SkinMedica for $350 Million

Code: E11161201

11-15-2012

Reckitt Benckiser to commence tender offer for Schiff Nutrition

Code: E11151201

11-14-2012

Forest, Adamas announce licensing agreement

Code: E11141200

11-13-2012

PerkinElmer acquires Shanghai Haoyuan Biotech to complement screening capabilities

Code: E11131201

11-12-2012

Myrexis decides to dissolve and liquidate assets

Code: E11121201

11-12-2012

Biocryst ends $234.8 million Phase III flu trial in disapppointment

Code: E11091201

11-12-2012

Hepatitis C on the A-list for pharmas this week

Code: E11141201

11-12-2012

GSK work on malaria vaccine suffers setback

Code: E11141202

11-12-2012

Cornell researchers reprogram amniotic fluid cells to treat vascular diseases

Code: E11141203

11-12-2012

Code: E11141204

November 2012

Meningitis outbreak plagues pharma industry

Code: E111225

November 2012

A third way for India

Code: E111226

November 2012

The great debate, 21st century-style

Code: E111227

November 2012

Obesity drugs may get faster FDA approval process

November 2012

New legislation addresses Calif. inspection policies

November 2012

NCI awards SBIR grant to Colby Pharmaceutical

November 2012

Matchmaking in the Midwest

Code: E111221

November 2012

Immunological inhibitor

Code: E111222

November 2012

MJFF invests $5 million in Vandy-BMS Parkinson’s collaboration

Code: E111223

November 2012

A tremendous trio

Code: E111224

November 2012

Life-science companies launch rare disease research competition

November 2012

Colby announces acquisition of Othera

November 2012

Celgene, VentiRx collaborate on TLR8 agonist

November 2012

Bend Research, Dow Chemical announce collaboration

November 2012

Innovation, visibility and survival

Code: E111217

November 2012

Of a giant and a gnome

Code: E111218

November 2012

Preparing to launch personalized medicine

Code: E111219

November 2012

HR-TOFMS for the metabolome

Code: E111220

November 2012

Synthetic Genomics acquires Febit’s genomics portfolio

November 2012

Foundation Medicine, Eisai collaborate on cancer trial

November 2012

Roche, Galaxy Biotech ink antibody license agreement

November 2012

Code: E111229

November 2012

Life Technologies acquires Compendia Bioscience

Code: E111209

November 2012

A new view for Bruker

Code: E111210

November 2012

REFS for a different kind of judgment call

Code: E111211

November 2012

Keeping methyltransferases simple

Code: E111212

November 2012

AB SCIEX, U of Wollonong to advance lipid analysis capabilities

November 2012

Tecan, JPT Peptide Technologies in co-promotion deal

November 2012

Horizon launches SyntheTx program with H3

November 2012

Takeda goes viral

Code: E111205

November 2012

Generating growth with Genfar

Code: E111206

November 2012

Making renal disease a top priority

Code: E111207

November 2012

Nanobodies for voltage-gated ion channels

Code: E111208

November 2012

Bayer-Evotec partnership targets endometriosis

November 2012

Japanese firms focus on cholesterol treatment

November 2012

RuiYi, ArGEN-X ink license deal for monoclonal antibody

November 2012

Narrowing in on NuroPro

Code: E111213

November 2012

Two new partners for Life

Code: E111214

November 2012

PROOF, MRM Proteomics turn the peptides

Code: E111215

November 2012

A diagnostic boost to therapeutic success

Code: E111216

November 2012

ERBA acquires Escalon Medical’s Dx business for $6.5 million

November 2012

Johns Hopkins, Iverson ink MDx licensing agreement

November 2012

Eutropics awarded NCI contract for leukemia diagnostic

November 2012

All for one, one for all

Code: E111201

November 2012

Toward early dementia intervention

Code: E111202

November 2012

A match made in MDS

Code: E111203

November 2012

Patent saga persists

Code: E111204

November 2012

Comprehensive miRNA sequencing

November 2012

RNA FISH probes for greater analysis capability

November 2012

Sterilizing-grade filters

November 2012

Powerful, versatile liquid handling

November 2012

Rapid, accurate mRNA, miRNA measurement

November 2012

Master mixes for simplified qPCR prep

November 2012

Neuroscience-specific mAb

November 2012

Changing dynamics in the pharma and biotech industries

November 2012

New roller rack for adherent cell culture

November 2012

I’m not sure about this, but …

November 2012

Serum-free cell culture media

November 2012

3D cell culture portal

November 2012

Preclinical screening for success determination

November 2012

PCR plate sealer

November 2012

Pharma industry awaits impact of Obama’s second term

November 2012

Online interface for sequencing panel creation

November 2012

Ultra-fine needle for neuroscience injections

November 2012

Signals in the noise (Part 1 of 2)

Code: E111228

November 2012

Extended pipette length for improved labware access

November 2012

Signals in the noise (Part 2 of 2)

November 2012

Exome target enrichment products

November 2012

New core-shell media offers high resolution, sensitivity

November 2012

Plug-and-play human genome interpretation system

November 2012

Microplate absorbance reader

November 2012

Lung cancer risk stratification test

November 2012

HTRF-based epigenetics toolbox

November 2012

Live cell research instrumentation promotion

November 2012

Sequencing consultation service

November 2012

Low-volume, cell-based assays

November 2012

CTCs isolation and analysis platform

11-08-2012

Wellcome Trust, MRC kick off $20 million iPS initiative

Code: E11071201

11-08-2012

Sun Pharmaceutical acquires DUSA, gains dermatology platform

Code: E11081201

11-07-2012

Takeda America Holdings to acquire Envoy

Code: E11061201

11-05-2012

Life Technologies acquires Advanced Microscopy Group

Code: E11051201

11-05-2012

Universities in the United Kingdom to see $1.6 billion in science funding

Code: E11021201

11-01-2012

MRC to provide $11 million in funding for AstraZeneca compound research

Code: E10311201

11-01-2012

Vertex to test hepatitis C compounds with Janssen and GSK

Code: E11011201

10-31-2012

Bayer announces acquisition plans for Schiff Nutrition

Code: E10301201

10-29-2012

Menarini, Oxford BioTherapeutics forge $1 billion cancer deal

Code: E10291201

10-25-2012

McKesson acquires PSS World Medical

Code: E10251201

10-24-2012

Seattle Genetics, Abbott expand ADC agreement

Code: E10231201

10-24-2012

Shire, Fondazione Telethon ink research collaboration

Code: E10241200

10-23-2012

Pfizer to acquire NextWave Pharmaceuticals for as much as $680 million

Code: E10241201

10-23-2012

Genzyme and Alnylam enter into exclusive RNAi development and commercialization alliance

Code: E10241202

10-23-2012

From cancer to Alzheimer's

Code: E10241203

10-23-2012

NYU School of Medicine breathes new life into mesothelioma research

Code: E10241204

10-22-2012

Dr. Reddy's Laboratories to acquire OctoPlus for $36 million

Code: E10221201

10-22-2012

Novo Nordisk gets positive news from Europe regarding insulin drugs

Code: E10191201

10-18-2012

BioCryst to acquire Presidio Pharmaceuticals for $101 million

Code: E10181201

10-17-2012

Merck announces partnerships in antiviral, cardiovascular therapeutics

Code: E10161201

10-17-2012

Horizon, WUSTL establish Center of Excellence

Code: E10171201

10-16-2012

Life-science companies launch rare disease research competition

Code: E10161202

10-15-2012

PharmAria and Celgene announce strategic partnership

Code: E10151201

10-15-2012

Benitec Biopharma acquires Tacere Therapeutics for $1.5 million

Code: E10121201

10-11-2012

GSK, Aeras partner to develop tuberculosis vaccine

Code: E10111201

10-10-2012

Washington University to spearhead extensive Alzheimer's initiative

Code: E10101200

10-10-2012

Life Technologies brings Compendia into the fold

Code: E10091201

October 2012

Being human: ASHG 2012 annual meeting preview

Code: E101218

October 2012

Filling a ‘critical’ gap

Code: E101209

October 2012

Leica Biosystems acquires Aperio

Code: E101210

October 2012

Seeking growth with Molegro

Code: E101211

October 2012

No gene left behind

Code: E101212

October 2012

AB Sciex, Sigma-Aldrich ink distribution agreement

October 2012

AssayMetrics-Cambridge collaboration focuses on assay technology

October 2012

Tecan, Siloam to co-market ELISA system

October 2012

Acquisition elevates Sunovion’s respiratory focus

Code: E101223

October 2012

Marching toward the front line

Code: E101224

October 2012

Fixing broken hearts

Code: E101225

October 2012

A window into VISTA

Code: E101226

October 2012

VLST secures Pfizer monoclonal antibody license

October 2012

Abbott, Astellas to collaborate on Phase III trial

October 2012

BioLineRx licenses hematological cancer drug candidate

10-09-2012

AstraZeneca gains license for Ardelyx's NHE3 inhibitor program

Code: E10101201

10-09-2012

Takeda to acquire LigoCyte Pharmaceuticals for $60 million

Code: E10101202

10-09-2012

MIT scientists see ‘lab-on-a-chip’ possibilities for biomedical research

Code: E10101203

10-09-2012

Auditing autism

Code: E10101204

10-08-2012

Optimer Pharmaceuticals to sell remaining ownership in Optimer Biotechnology for $60 million

Code: E10081201

10-08-2012

Mayne Pharma to acquire Metrics Inc. in deal worth as much as $120 million

Code: E10051201

October 2012

Company complements are more than skin deep

Code: E101201

October 2012

Court upholds federal hESC research funding

Code: E101202

October 2012

Treasure in the junk

Code: E101203

October 2012

Intel inside Ivy

Code: E101204

October 2012

Barcodes in drug discovery: The quiet revolution

October 2012

Who needs R&D tax credits?

October 2012

When the medium isn’t the message anymore

October 2012

qPCR for absolute quantitation

October 2012

Single cell expression assay

October 2012

Neurite outgrowth measurement kit

October 2012

Air displacement liquid handling arm

October 2012

RNA reagent kits for full transcriptome view

October 2012

New generation of bioreactor

October 2012

Vegetable-based contact agar

October 2012

Scalable target capture probes

October 2012

Acoustic liquid dispensing array

October 2012

Packed-bed, single-use vessel

October 2012

Accurate expression data from older FFPE samples

October 2012

Microplate options for increased flexibility, performance

October 2012

Chromatography media for downstream processing

October 2012

Automated optimizer for crystallography

October 2012

Upgrade to molecular biology software suite

October 2012

A companion in your corner (Part 1)

Code: E101231

October 2012

A companion in your corner (Part 2)

Code: E101231

October 2012

Charles River acquires Accugenix

Code: E101227

October 2012

QPS acquires JSW Life Sciences, Austria’s largest independent CRO

Code: E101228

October 2012

A venture in the East

Code: E101229

October 2012

From Ireland with love

Code: E101230

October 2012

Life Technologies links up with Sino Biological

October 2012

Cobra inks agreement with Algeta ASA

October 2012

Gentronix, Kowa partner on screening collaboration

October 2012

Paradigm for personalized medicine

Code: E102114

October 2012

A picture-perfect focus

Code: E101215

October 2012

Partners target ovarian cancer

Code: E102116

October 2012

PathGEN inks pact with Affymetrix

Code: E101217

October 2012

Agios, UPenn announce cancer Dx collaboration

October 2012

GeneCentric launches with UNC licenses

October 2012

Islet Sciences licenses diabetes diagnostic from Winthrop U

October 2012

Adding mixtures to the mix

Code: E101205

October 2012

Going through a phage

Code: E101206

October 2012

Code: E101207

October 2012

Code: E101208

October 2012

AstraZeneca to test Starpharma’s dendrimer molecules

October 2012

BioFocus, Ono collaborate on CNS drug discovery

October 2012

Studies highlight role of GM-CSF in pain

October 2012

An infectious attitude

Code: E101219

October 2012

Three partners, one target

Code: E101220

October 2012

An alternative to liver transplantation

Code: E101221

October 2012

Collaborators seek MS biomarkers

Code: E101222

October 2012

NHGRI prepares for reorganization

October 2012

Silence, MiReven ink tumor collaboration

October 2012

AGI gains whole-genome profiling license from KeyGene

10-04-2012

Partners to develop, commercialize agonist for gastroparesis

Code: E10031201

10-04-2012

Horizon, H3 Biomedicine kick off SyntheTx program

Code: E10041201

10-03-2012

Janssen, Astellas announce license agreement

Code: E10021201

10-01-2012

FDA approves Abbott Laboratories' Humira as ulcerative colitis therapy

Code: E10011201

09-28-2012

Teva purchases Huntington disease compound rights from NeuroSearch A/S

Code: 09271201

09-27-2012

European project to produce handheld malaria diagnosis device

Code: E09261200

09-26-2012

Medicago, PMP ink licensing agreement

Code: E09251201

09-25-2012

Complete Genomics Inc. to be acquired by Chinese firm BGI-Shenzhen for $117.6 million

Code: E09261201

09-25-2012

Valeant Pharmaceuticals acquires ophthalmic compound Visudyne for $112.5 million

Code: E09261202

09-25-2012

Scripps Research article describes new way to discover therapeutic antibodies

Code: E09261203

09-25-2012

MuSK musters hope for ALS treatment

Code: E09261204

09-24-2012

Peregrine stock price plunges on news of discrepanies in bavituximab trial

Code: E09241201

09-20-2012

Playing with DARTs

Code: E09201201

09-19-2012

Illumina lands FDA contract

Code: E09181201

09-19-2012

Baxter, Onconova ink licensing agreement

Code: E09191201

September 2012

CDx, cancer and collaborations: Take our reader survey

09-17-2012

Life Technologies to partner with Bristol-Myers Squibb for companion diagnostics development

Code: E09171201

09-17-2012

New NIH/NHGRI grants for harnessing nanoscale technologies to cut DNA sequencing costs

Code: E09141201

September 2012

New molecular probes kit

September 2012

Bromodomain assay kits

September 2012

Ready-to-use cDNA clones

September 2012

Copy number variation workflow

September 2012

Easy-to-use modular chromatography system

September 2012

MSDs for increased operational, cost efficiency

September 2012

Fatty acid oxidization reagent

September 2012

Efficient, label-free 96-well plate

September 2012

Immunoassays for high specificity

September 2012

Upgraded open-source organic chemistry toolkit

September 2012

CE certified automated sample prep system

September 2012

Low heat, noise output centrifuge

September 2012

Parallel processing for shorter image analysis times

September 2012

Single-step PARG inhibition assay

September 2012

Aptamers for antibody target issues

September 2012

Compact microplate reader

September 2012

NGS service for personalized medicine

September 2012

New user-friendly bioreactor series

September 2012

Dynamic process and interaction observation at atomic levels

09-13-2012

Oncodesign announces Sanofi collaboration

Code: E09131201

09-12-2012

Vascular Pharmaceuticals, Janssen announce agreement

Code: E09121200

September 2012

Looking to build a bit of synergy

Code: E091221

September 2012

Code: E091222

September 2012

Stem cells on the brain

Code: E091223

September 2012

Attention to detail

Code: E091224

September 2012

BMS, Prosetta alliance to focus on antivirals

September 2012

Oncobiologics, XOMA ink collaboration

September 2012

New Jersey sees biotech growth

September 2012

AstraZeneca goes virtual

Code: E091209

September 2012

One byte at a time

Code: E091210

September 2012

A multiplex menu

Code: E091211

September 2012

A pair for the win

Code: E091212

September 2012

Infrared dye-labeled peptides from CRB, LI-COR

September 2012

iBio, GE Healthcare announce second agreement

September 2012

Sigma, Axiogenesis ink marketing agreement

September 2012

Meeting of the minds

Code: E091229

09-11-2012

GlaxoSmithKline opens research unit to study traditional Chinese medicine

Code: E09121201

09-11-2012

Merck Serono expands EGFR-targeted portfolio

Code: E09121202

09-11-2012

Cornering cathepsins

Code: E09121203

09-11-2012

MIT-Harvard study yields insight into cell growth and division

Code: E09121204

09-11-2012

Pfizer to partner with Visterra

Code: E09111201

09-10-2012

Peregrine drug reportedly doubles lung cancer survival in trial

Code: E09101201

09-09-2012

SFJ Pharma to co-develop dacomitinib with Pfizer

Code: E09071201

09-06-2012

Entelos signs contract with FNIH for biomarker consortium

Code: E09051201

September 2012

High risk, high payoff

Code: E091213

September 2012

A partnership with a firm Foundation

Code: E091214

September 2012

From under the sea

Code: E091215

September 2012

GenMark goes ALL-digital

Code: E091216

September 2012

BioFocus to offer Activiomics’ proteomics services

September 2012

Transgenomic, MCW ink collaboration

September 2012

Affymetrix, Siemens expand license

September 2012

Synergy among neighbors

Code: E091205

September 2012

Lonza announces license agreement with iPS Academia Japan

Code: E091206

September 2012

Calling the X-MAN to battle cancer gene

Code: E091207

September 2012

All systems Funxional

Code: E091208

September 2012

Neurodyn acquisition creates largest neurology-focused firm in Canada

September 2012

Teva, P&G announce Indian production plant

September 2012

Commercialization agreement for respiratory portfolio

September 2012

Second verse, same as the first

Code: E091225

September 2012

Stem cells can be regulated as drugs, court says

Code: E091226

September 2012

Sun comes out for orphan diseases

Code: E091227

September 2012

Fewer approvals forecast for 2012

September 2012

NIH launches grant program

September 2012

BMS exec arrested for insider trading

September 2012

Circuit-makers target genetic bottlenecks

Code: E091217

September 2012

Study unveils genetic underpinnings of PTSD

Code: E091218

September 2012

Closing the circle on Huntington’s disease

Code: E091219

September 2012

Going after GPCR

Code: E091220

September 2012

Benitec, Medistem announce transplant paper publication

September 2012

CHUM to lead prostate cancer biomarker effort

September 2012

Agilent establishes new Daegu center

09-06-2012

Symphogen licenses EGFR antibody mixture to Merck

Code: E09061201

09-05-2012

Valeant nabs Medicis for $2.6 billion

Code: E09041201

September 2012

Curing disease at the genetic level

Code: E091201

September 2012

Disease in a dish

Code: E091202

September 2012

Tiny brain, huge potential

Code: E091203

September 2012

Code: E091204

September 2012

Genetic therapies? The heck, you say!

September 2012

Out of Order: If you build it …

September 2012

Working together to eradicate cell line misidentification and contamination: New practices and policy

08-31-2012

Janssen Biotech, Genmab sign potential $1 billion deal

Code: E08301201

08-30-2012

Sequenom completes distribution agreements

Code: E08281201

08-30-2012

Sunovion to acquire Elevation Pharmaceuticals

Code: E08291201

08-27-2012

Agilent acquires assets of Aurora

Code: E08271201

08-27-2012

Is the promise of emerging markets wishful thinking?

Code: E08241201

08-24-2012

Pfizer, Mylan to partner on generics in Japan

Code: E08231201

08-23-2012

Trangenomic seeks to develop early detection tools for pancreatic cancer

Code: E08221201

08-21-2012

GlaxoSmithKline drug halves attacks in hard-to-treat asthma

Code: E08221201

08-21-2012

A bidding war to come for Strides-owned injectables unit?

Code: E08221202

08-21-2012

MIT’s latest SIRT1 research links dietary stress and predisposition to metabolic dysfunction

Code: E08221203

08-21-2012

Talking with cells

Code: E08221204

08-21-2012

Keeping an eye on DARPins

Code: E08211200

08-20-2012

Cinven acquires Mercury Pharma

Code: E08201201

08-20-2012

Mylan Pharmaceuticals gets FDA nod for generic Actos

Code: E08171201

08-16-2012

University of Utah receives $16 million NIH grant

Code: E08151201

08-16-2012

TG Therapeutics, Rhizen to collaborate on PI3K delta inhibitor

Code: E08161201

08-15-2012

GNS, CHDI to develop computer models of Huntington's

Code: E08141201

08-13-2012

Sun Pharmaceutical to take Taro Pharmaceutical private for $571 million

Code: E08131201

08-13-2012

Eli Lilly realizes $790 million in income from Amylin Pharmaceuticals

Code: E08101201

08-10-2012

Wellcome Trust, MRC to fund Cambridge stem cell center

Code: E08091201

August 2012

Code: E081227

August 2012

Global peptide partnership

Code: E081228

August 2012

AMAG moves to outsource manufacturing

August 2012

Cyprotex, Sirius Analytical announce alliance

August 2012

New forecast for CRO markets in Indonesia, Philippines

August 2012

Purification systems for degassed water

August 2012

Screens for early drug discovery phases

August 2012

RNA sequencing kits for humans, mice, rats

August 2012

Enumerate and characterize CTCs

August 2012

Customizable enrichment solution

August 2012

Increased Y-STR loci detection for forensics

August 2012

Supply portfolio for increased performance, productivity

August 2012

Positive displacement liquid dispensing

August 2012

Purified human proteins from HEK293 cells

August 2012

Bovine, ovine dendritic cell kits

August 2012

Simultaneous O2, CO2 concentration control

August 2012

New platform for next-gen data analysis

August 2012

Monoclonal antibodies for Mycoplasma genitalium

August 2012

3D cell cultures for cellular study

August 2012

DNA-seq kits for Ion Torrent

August 2012

Trio of Factor VII detection methods

08-09-2012

Synthetic Biologics, Intrexon launch second partnership

Code: E08081201

August 2012

Tegal acquires CollabRx

Code: E081213

August 2012

Eyes on the Ion

Code: E081210

August 2012

Stepping up to the platform

Code: E081211

August 2012

KREATECH Diagnostics, ORIDIS Biomarkers go FISH

Code: E081212

August 2012

QIAGEN to create NGS portfolio for clinical research, MDx

August 2012

Of warheads and wellness

Code: E081205

August 2012

Tackling the TB epidemic

Code: E081206

August 2012

Vela, Eppendorf announce collaboration on diagnostic platform

August 2012

An acquisition with some heart

Code: E081207

August 2012

CRB, LI-COR ink license deal for peptide labeling

August 2012

Distribution agreement for Asia, Latin America

August 2012

MCPs for COPD and asthma

Code: E081208

August 2012

Collaboration targets complications

Code: E081221

August 2012

GSK finalizes Human Genome Sciences acquisition for $14.25 per share in cash

August 2012

CoMMpass to multiple myeloma treatment

Code: E081222

August 2012

University of Cambridge in R&D pact with GSK

August 2012

Daiichi Sankyo, Ranbaxy look to Venezuela

August 2012

Biogen Idec, Isis partner on antisense drug

August 2012

A cognitive collaboration

Code: E081223

August 2012

A bioscaffold for heart disease repair

Code: E081224

August 2012

MagForce partners with Mayo Clinic

August 2012

Fluxion, Stanford School of Medicine team up

August 2012

MJFF funds KineMed biomarker research

August 2012

Discovery on demand

Code: E081217

August 2012

Zebrafish turn the tide in autism research

Code: E081218

August 2012

Cold Spring Harbor Lab, Pfizer partner on cancer therapy research

Code: E081219

August 2012

Code: E081220

August 2012

ILS forms genomics venture

August 2012

BGI, CHOP team up on rare diseases

August 2012

VTT, GE Healthcare collaborate on Alzheimer’s biomarkers

August 2012

Going primetime with real-time PCR

Code: E081213

August 2012

Custom-tailored therapy

Code: E081214

August 2012

Breaking the Parkinson’s bottleneck

Code: E081215

August 2012

Lilly, PrimeraDx break the ICE

Code: E081216

August 2012

Double optical path system for fluorescence assays

August 2012

Theradiag acquires Prestizia, microRNA technology platform

August 2012

BD secures license to Asuragen’s MDx technology

August 2012

Trovagene, MD Anderson target KRAS mutations

August 2012

Licensing agreement formed by PDI, Polymedco

August 2012

Renaissance Pharma acquires DPT, a CDMO

Code: E081225

August 2012

Solving the insoluble

Code: E081226

08-07-2012

Alzheimer’s drug gets boot by Pfizer and Johnson & Johnson after Phase III program failure

Code: E08071201

08-07-2012

Novartis gains immune-cell cancer therapy in deal with University of Pennsylvania

Code: E08081201

08-07-2012

FDA approves generic versions of Singulair

Code: E08081202

08-07-2012

Informing on inflammation

Code: E08081203

08-07-2012

City of Hope researchers offer hope for less invasive prostate cancer diagnosis

Code: E08081204

08-07-2012

Saladax enters into master collaboration agreement with Bristol-Myers Squibb

Code: E08061201

August 2012

Surprising and sizable injection

Code: E081201

August 2012

Valeant all smiles over OraPharma

Code: E081202

August 2012

Hiding in plain sight

Code: E081203

August 2012

The life science DREAM team

Code: E081204

August 2012

SPECIAL REPORT: Regenerating interest in stem cell medicine (PART 1)

Code: E081229

August 2012

SPECIAL REPORT: Regenerating interest in stem cell medicine (PART 2)

Code: E081230

August 2012

The promise of cell therapies in treating chronic diseases

August 2012

August is back-to-school month

August 2012

Public misconceptions about stem cells throw a wrinkle into scientific progress

08-03-2012

NYGC announces launch of Innovation Center

Code: E08021201

08-02-2012

Alseres, Navidea team up for Parkinson’s diagnostic agent

Code: E08011201

07-31-2012

Cleveland BioLabs announces Russian contract agreement

Code: E07311201

07-31-2012

Pfizer terminates license to three products with Acura Pharmaceuticals

Code: E07301201

07-29-2012

Amarin Corp.'s fish oil drug wins FDA approval to treat high blood fat levels

Code: E07271201

07-27-2012

UWA, Agilent announce five-year collaboration

Code: E07261201

07-26-2012

University of Edinburgh, BGI announce MOU

Code: E07251201

07-25-2012

Forest, Almirall get green light for COPD treatment

Code: E07241201

07-24-2012

Chimerix signs worldwide license agreement with Merck & Co. for up to $168.5 million

Code: E07251201

07-24-2012

Fresenius Kabi AG acquires Fenwal

Code: E07251202

07-24-2012

‘QC’ process for cell development identified in Scripps Florida study

Code: E07251203

07-24-2012

Alleviating Alzheimer’s

Code: E07251204

07-23-2012

Boehringer Ingelheim acquires Funxional Therapeutics’ FX125L compound

Code: E07231201

07-23-2012

FDA approves Onyx Pharmaceuticals' Kyprolis for multiple myeloma

Code: E07201201

07-21-2012

Amicus, GSK announce collaboration expansion

Code: E07191201

07-19-2012

Innophos acquires AMT Labs for $27 million

Code: E07181201

07-18-2012

Thermo Fisher to acquire One Lambda for $925 million

Code: E07171201

07-17-2012

GSK to acquire Human Genome Sciences for $14.25 per share in cash

Code: E07161201

07-13-2012

UC Davis, Agilent, FDA announce genome project

Code: E07121201

07-13-2012

Carl Zeiss licenses digital pathology patents from Olympus

Code: E07131201

07-12-2012

HemoShear, Expression Analysis announce partnership

Code: E07111200

07-11-2012

All about the algorithms

Code: E07101201

July 2012

Plate reader with on-board camera

July 2012

Cell isolation and processing for genomic analysis

July 2012

Catalogued assay for RNA FISH research

July 2012

High flexibility, performance for high-pressure applications

July 2012

First real-time multiplex quantification assay for respiratory diseases

July 2012

Novel cell manipulation and analysis platforms

July 2012

LNA enhanced qPCR assay design tool

July 2012

Cell-cell interaction analysis

July 2012

Polystyrene plates for cell cultivation

July 2012

New luciferase for better reporter applications

July 2012

Size exclusion columns for biomolecules

July 2012

Knockout rats for pharmacokinetic studies

July 2012

New system for sensor management and integration

July 2012

Next-generation diagnostic data analysis

July 2012

Whole-genome interpretation software

07-09-2012

Luminex to acquire GenturaDx for $50 million

Code: E07091201

07-09-2012

Human Genome Sciences in the crosshairs

Code: E07061201

07-09-2012

Prokarium acquires oral vaccine technology from Emergent BioSolutions

Code: E07091202

07-09-2012

Janssen Pharmaceuticals enters alliance with CureBeta that could top $300 million in value

Code: E07111201

07-09-2012

ERT acquires invivodata

Code: E07111202

07-09-2012

New study reveals dynamic changes in gene regulation of human pluripotent stem cells

Code: E07111203

07-09-2012

A shot in the arm for smokers

Code: E07111204

July 2012

Integrated digital pathology image analysis

July 2012

Multichannel reagent reservoirs

July 2012

Electrofusion system for higher efficiencies

July 2012

A pair of Northern lights

Code: E071221

July 2012

Last man standing

Code: E071213

July 2012

Racking the brain

Code: E071222

July 2012

Taking a long, hard look at HER

Code: E071223

July 2012

On the hunt for Huntington’s disease therapy

Code: E071224

July 2012

Tau Therapeutics and NCI launch Phase Ib trial in brain cancer

July 2012

SCRI, YCC, SCH announce collaboration

July 2012

Astellas announces second Drais partnership

July 2012

Spanning the melanoma continuum

Code: E071214

July 2012

Forest, Nabriva to develop antibacterial compound

July 2012

Code: E071215

July 2012

Exosome chooses Life

Code: E071216

July 2012

Transgenomic acquires clinical sample biorepository from Gene Logic

July 2012

OSEO grants Exonhit $2.4 million for cancer research

July 2012

Trovagene, Strand sign MOU

July 2012

Agendia nets $65 million for cancer tests

July 2012

Art of the deals

Code: E071205

July 2012

Brazil beckons to Belgium

Code: E071206

July 2012

Just what the doctor ordered

Code: E071207

July 2012

Probing the bowels of disease

Code: E071208

July 2012

Bayer enters into strategic partnership with Covance

July 2012

Enamine, MRC LMB, IOCB announce alliance

July 2012

India’s BHU to launch stem cell center

July 2012

Isogenica, Cresset, Biolauncher gain funding

July 2012

No more ‘garbage in, garbage out’

Code: E071209

July 2012

Pop-up informatics

Code: E071210

July 2012

A*STAR for Hitachi

Code: E071211

July 2012

Harnessing ISH and IHC

Code: E071212

July 2012

Corning announces cell-culture automation collaboration with TAP Biosystems

July 2012

License agreement to cover ORNL technologies

July 2012

Tecan, Reinnervate ink marketing agreement

July 2012

ATCC, Promega announce license agreements

July 2012

From pilot to partners

Code: E071217

July 2012

New on the singles scene

Code: E071218

July 2012

Real-time liquid biopsy

Code: E071219

July 2012

An A+ partnership on hemophilia B

Code: E071220

July 2012

BGI, Asian Cancer Research Group publish genome-wide study of hep B virus

July 2012

Komen awards $5.4 million for cancer screening effort

July 2012

Alnylam gains PBL license

July 2012

SAU, LC Sciences map obesity epigenetics

July 2012

Taking the fifth

Code: E071225

July 2012

I spy with my little eye …

Code: E071226

July 2012

California bill seeks restrictions on genetic data

Code: E071227

July 2012

Epigenetics: Half of the picture (PART 1)

Code: E071229

July 2012

NIH grants $800,000 to CHOP

July 2012

Casting a clinical eye

Code: E071201

July 2012

Does persistence pay off?

Code: E071202

July 2012

Supreme Court decision delivers clarity to generic drugmakers

Code: E071203

July 2012

Therapeutic Discovery Project championed

July 2012

J&J unit receives FDA warning letter

July 2012

International team tackles cancer

Code: E071204

July 2012

Meeting the need for large-scale production of stem cells

July 2012

Out of Order: Good news and good luck

July 2012

Crohn’s a very personal disease

07-05-2012

Merck, MDxHealth expand collaboration

Code: E07051201

July 2012

Epigenetics: Half of the picture (PART 2)

Code: E071230

07-04-2012

Bristol-Myers Squibb to acquire Amylin Pharmaceuticals

Code: E07031201

07-02-2012

GSK settles healthcare fraud case for $3 billion

Code: E07021201

07-02-2012

Antibody deal struck for possible $500M-plus and neuromuscular deal for up to $271M

Code: E06291201

06-29-2012

KineMed receives $1.2 million from MJFF

Code: E06281201

06-28-2012

BioClinica, C.R. Bard win Microsoft award

Code: E06271200

06-27-2012

Pharma hit by additional layoffs

Code: E06261200

06-26-2012

EMA acts on alleged deficiencies in Roche’s reporting of medicines’ safety

Code: E06271201

06-26-2012

Compugen, Merck Serono to jointly establish biomarker company Neviah Genomics

Code: E06271202

06-26-2012

Canadian researchers probe nitroglycerin’s effectiveness in treating prostate cancer

Code: E06271203

06-26-2012

Learning when to fold

Code: E06271204

06-25-2012

Pfizer and Bristol-Myers Squibb fail to win FDA approval for Eliquis

Code: E06251201

06-22-2012

Brisk week for the FDA

Code: E06211201

06-22-2012

Xanodyne Pharmaceuticals sells drug for $26 million to Depomed

Code: E06221201

06-20-2012

AstraZeneca, Rigel announce license agreement

Code: E06191201

06-20-2012

New collaboration heads Seaside

Code: E06201201

06-19-2012

AC Immune and Genentech enter into second antibody collaboration for Alzheimer’s disease

Code: E06181201

06-15-2012

Upsher-Smith to acquire Proximagen

Code: E06141201

06-15-2012

Valeant Pharmaceuticals to acquire OraPharma for $312 million

Code: E06151201

06-14-2012

Jazz Pharmaceuticals finalizes EUSA Pharma acquisition

Code: E06131200

06-13-2012

Hunting down Huntington's disease

Code: E06121201

06-11-2012

FDA approves Roche's Perjeta for people with HER2-positive metastatic breast cancer

Code: E06111201

06-11-2012

GlaxoSmithKline extends tender offer for Human Genome Sciences by three weeks

Code: E06081201

06-11-2012

Johnson & Johnson rumored to be paying as much as $2.2 billion to settle U.S. drug marketing charges

Code: E06131201

06-11-2012

GSK subsidiary pays $227 million for rights to Basilea Pharmaceutica eczema drug

Code: E06141202

06-11-2012

IU researchers visualize better treatments for eye disease

Code: E06131203

06-11-2012

Playing it cool with PRMT1

Code: E06131204

June 2012

Sealable sample vials for decreased contamination risk

June 2012

Targeted transgenic integration within rat genome

June 2012

Retinoic acid receptor assays

June 2012

Compact liquid handler for space management

June 2012

Automated analysis and sorting of cell clusters

June 2012

Purification kits for high-yield chiral screening

June 2012

Custom antibody conjugate design service

June 2012

Image analysis for chemiluminescent blots and gel imaging

June 2012

New trio of assays for kinase screening

June 2012

Specialist equipment for potent compound processing

June 2012

Microplate washer suited for robotic installations

June 2012

Genome-exploration app for the iPad

June 2012

Reagents for safe, noninvasive siRNA delivery

June 2012

Monoclonal antibodies for U. parvum

June 2012

Microscope system for biomedical applications

June 2012

Companies create ‘road atlas’ of human biology

Code: E061209

June 2012

‘Mainlining’ research content to scientists

Code: E061210

June 2012

Getting everyone’s heads in the cloud

Code: E061211

June 2012

Dolomite joins forces with LioniX

Code: E061212

June 2012

Ambry Genetics launches Fluidigm-based genomic research services

June 2012

GE Healthcare, Refine Technology ink agreement

June 2012

Strategic collaboration bears fruit

June 2012

Lonza, Agennix begin manufacturing deal

June 2012

New class is in session

Code: E061217

June 2012

Creating a new oral tradition

Code: E061218

June 2012

Fresh horizons in drug discovery

Code: E061219

June 2012

Two down, 94 to go

Code: E061220

June 2012

BGI and several academic partners to sequence 100 human adenoviruses

June 2012

Takeda, Metabolon launch research alliance

June 2012

Arrowhead Research completes Alvos acquisition

June 2012

BCM receives $781,455 in DOD awards

June 2012

Right on TARGET

Code: E061221

June 2012

Long court battle over stem cell research continues

Code: E061223

June 2012

NCATS finds new tricks for old dogs

Code: E061222

June 2012

Accelerated development

Code: E061224

June 2012

Tolero, MannKind ink license agreement

June 2012

Dyax grants Eclipse technology license

June 2012

Sanofi collaborates with MJFF on Parkinson’s disease treatment

06-07-2012

AFFiRiS AG takes Parkinson's vaccine to trials

Code: E06071201

06-07-2012

Estrogen compound seen to suppress tumor growth

Code: E06071202

June 2012

Raising the third pillar

Code: E061225

June 2012

Spain and France join hands

Code: E061226

June 2012

Partnering for Phase III

Code: E061227

June 2012

Hustling on half-lives

Code: E061228

June 2012

AMRI inks deal with Biota Holdings

June 2012

BioClinica, Paragon announce partnership

June 2012

CROs link up in strategic alliance

June 2012

AMRI introduces SMARTSOURCING

June 2012

Childhood cancer collaboration

Code: E061213

June 2012

The way to man’s heart—through his stomach

Code: E061214

June 2012

A hankering for HER2

Code: E061215

June 2012

NGS for cancer Dx

Code: E061216

June 2012

QIAGEN joins POC Dx Initiative

June 2012

Pressure Bio, Target Discovery expand collaboration

June 2012

Rockland to market LDI’s antibodies

June 2012

Rainbow, Amarantus announce LOI

June 2012

Turning toward Turkey

Code: E061205

June 2012

Australian pharma nabs U.S. shareholders

Code: E061206

June 2012

A duo that’s sweet on new biomarkers

Code: E061207

June 2012

A joint research project

Code: E061208

June 2012

Evotec licenses inflammatory disease compounds to Chinese pharma

June 2012

Watson adds action and strength to generics position

Code: E061201

June 2012

Stretching its wings

Code: E051202

June 2012

Sandoz acquires Fougera Pharmaceuticals

Code: E061203

June 2012

Code: E061204

June 2012

Zealand Pharma inks license agreement with Abbott

June 2012

Pluristem secures grant for R&D

June 2012

Release of proposed AMP rule creates new issues for life-science industry

June 2012

Nanobiotix, TJU partner on preclinical research program

June 2012

Making decisions … and making them work

June 2012

Michael J. Fox drives stem cell research efforts for Parkinson’s disease back to the future

06-06-2012

Baxter, Chatham partner on hemophilia treatments

Code: E06061201

06-05-2012

Genmab to partner with Novartis on antibodies

Code: E06051201

06-04-2012

A triple-play against cancer

Code: E06041201

06-04-2012

Forest gains access to antibacterial, sets up for possible acquisition

Code: E06011201

06-01-2012

PCGP announces release of 520 genome sequences

Code: E05311201

05-31-2012

City of Hope receives $5.2 million from CIRM

Code: E05301201

05-24-2012

NIH awards Lucigen $2.8 million SBIR grant

Code: E05231200

05-24-2012

GSK, AstraZeneca join others in antibiotic research program

Code: E05241201

05-22-2012

Agilent to acquire Danish company Dako for $2.2 billion

Code: E05231201

05-22-2012

‘Class equals function’ in Scripps immunology study

Code: E05231203

05-22-2012

Timing is everything

Code: E05231204

05-21-2012

iPierian advances monoclonal antibody drug development programs

Code: E05211201

05-21-2012

Osiris becomes trailblazer in stem cell therapy market with Prochymal approval

Code: E05181201

05-18-2012

HGS enacts 'poison pill' defense against GSK acquisition

Code: E05171201

05-17-2012

GSK to acquire Cellzome for $99 million

Code: E05161201

05-15-2012

Cornerstone, EKR Therapeutics ink definitive merger agreement

Code: E05151201

05-14-2012

Rib-X postpones initial public offering after cutting price in half

Code: E05111201

05-14-2012

OncoMed Pharma files for IPO

Code: E05141201

05-11-2012

Broad Institute, Fluidigm launch Single-Cell Genomics Center

Code: E05101201

May 2012

More about asm2012 and San Francisco

Code: E051290

May 2012

GE ropes in Texas genomics company

Code: E051213

May 2012

BMS opts for MULTI-ARRAY

Code: E051214

May 2012

B cells on the A-list

Code: E051215

May 2012

Scratching out allergies

Code: E051216

May 2012

Roche throws in the towel

Code: E051230

May 2012

MMRF, TGen to lead multiple myeloma study

May 2012

ALL, GenMark to develop in-vitro diagnostic platform

May 2012

Horizon, EMQN partner for EQA

May 2012

Myriad, Cephalon announce CDx agreement

May 2012

High efficiency, low enrichment bias for DNA enrichment

May 2012

Solutions for bioanalytical workflow challenges

May 2012

New series offers multiple centrifuge options

May 2012

Imaging systems offer three times the throughput, significant time savings

May 2012

96-well plate-based chromatin immunoprecipitation

May 2012

Tissue-specific conditional gene knockout in rats

May 2012

Assay service for characterization of immune responses

May 2012

microRNA qPCR panels feature increased sensitivity

May 2012

Liquid-handling workstation with small benchtop footprint

May 2012

New range of product offerings for cancer research

May 2012

Optimized analysis of cancer genes in FFPE samples

May 2012

Automated image analysis for brightfield and fluorescence digital pathology

May 2012

Barcode reader allows for simultaneous scanning of up to 100 samples

May 2012

Quick and simple glycolytic measurement

May 2012

Arrays offer greater options in mAb analysis

May 2012

Spectrum diversifies its revenue

Code: E051221

May 2012

Clinical-stage collaboration

Code: E051222

May 2012

Shire stakes a claim

Code: E051223

May 2012

AMRI licenses anticancer tubulin inhibitor program to Bessor Pharma

Code: E051224

May 2012

Sigma-Aldrich acquires Research Organics, strengthens portfolio of PharmaGrade raw materials

May 2012

Millennium, Presage ink research agreement

May 2012

GSK to invest in new jobs, manufacturing facility

May 2012

Collaboration to advance brain drug candidates

May 2012

Researchers have the stomach for cancer

Code: E051217

May 2012

A virtual encyclopedia

Code: E051218

May 2012

Cars, remote controls and McDonalds

Code: E051219

May 2012

PROOF positive about working with Adiga

Code: E051220

05-09-2012

GSK takes acquisition offer to HGS shareholders

Code: E05091200

May 2012

Agilent and FAPESP fund life-science research projects in Brazil

May 2012

Proteome Sciences licenses biomarker portfolio to Randox

May 2012

International alliance to support pharmacogenetics

May 2012

Research partnership offers variety of services

May 2012

President Obama signs JOBS Act

Code: E051225

May 2012

Under the looking glass

Code: E051226

May 2012

COMMENTARY: Laws of nature muddle patent certainty

May 2012

J&J racks up Risperdal fines

May 2012

New bill to speed approval for breakthrough drugs

May 2012

2009-2011 biotech lobbying totals $40 million in California

May 2012

Going for multiple shots on goal

Code: E051229

05-09-2012

Bayer Yakuhin, Santen announce co-promotion agreement

Code: E05081200

05-08-2012

Abbott pays big price to settle on Depakote

Code: E05081201

05-08-2012

Some Big Pharma players face uphill struggles

Code: E05081202

05-08-2012

From diabetes to DMD

Code: E05081203

05-08-2012

Swiss research team uses stem cell ‘cardiopatches’ to treat infarcted mice

Code: E05081204

May 2012

Mayo yes, Myriad maybe

Code: E051201

May 2012

Crystal-clear acquisitions

Code: E051202

May 2012

A deal with 20/20 vision

Code: E051203

May 2012

Forming a pharma fund

Code: E051204

May 2012

Michigan university, lawmakers at impasse over hESCs

May 2012

Getting the big picture from small sources

Code: E051228

May 2012

Code: E051209

May 2012

Out of Order: Patently absurd

May 2012

Paradigm shift: Rethinking type 2 diabetes as a heterogeneous disease

May 2012

Beckman Coulter sets sail with Blue Ocean

Code: E051210

May 2012

Sequencing in the palm of your hand?

Code: E051211

May 2012

BioClinica’s PET project

Code: E051212

May 2012

Japan’s Transparent, Molecular Response to launch 3D cell culture system for cancer applications

May 2012

Shimadzu announces new center at UT Arlington

May 2012

Almac, Affymetrix ink distribution deal

May 2012

U of Michigan employs TTP Labtech mosquito pipettor

May 2012

Across the (other) pond

Code: E051205

May 2012

Code: E051206

May 2012

A French-American alliance

Code: E051207

May 2012

Israeli researchers develop vaccine to fight cancer

Code: E051208

May 2012

Fujifilm, Kyowa Hakko Kirin launch biosimilars joint venture

May 2012

BioSeek, Merck Serono extend partnership

May 2012

Daiichi Sankyo, NGM partner up

May 2012

Compugen establishes mAb development facility

05-03-2012

Novartis to acquire Fougera Pharmaceuticals for $1.5 billion

Code: E05031201

05-02-2012

Multicenter partnership to sequence adenoviruses

Code: E05021201

05-01-2012

Novo Nordisk, Caisson Biotech announce license agreement

Code: E05011201

04-30-2012

Hologic to acquire Gen-Probe for $3.7 billion

Code: E04301201

04-27-2012

New acquisition to expand Amgen's presence in Turkey

Code: E04251201

04-27-2012

Jazz Pharmaceuticals buying EUSA Pharma for as much as $700 million

Code: E04271201

04-26-2012

Epizyme, Celgene announce strategic partnership

Code: E04261200

04-24-2012

AstraZeneca to acquire Ardea Biosciences for $1.26 billion

Code: E04251201

04-24-2012

After plan to acquire Illumina is scuttled, speculations begin on Roche next steps

Code: E04251202

04-24-2012

Scripps Research scientists synthesize compounds that dramatically alter circadian rhythms

Code: E04251203

04-24-2012

The proof is in the progenitors

Code: E04251204

04-24-2012

Bayer expands targeted cancer therapy collaboration with Amgen

Code: E04241200

04-23-2012

Nabi Biopharmaceuticals merges with Biota Holdings

Code: E04231201

04-20-2012

Aspen Phamacare buys GlaxoSmithKline OTC products for $263 million

Code: E04201201

04-20-2012

Human Genome Sciences turns down GSK's $2.6 billion offer

Code: E04191201

04-18-2012

Roche announces tender offer will not be extended

Code: E04181201

04-17-2012

Merck, Endocyte ink agreement for cancer drug candidate

Code: E04171201

04-13-2012

PhRMA reports $49.5 billion in R&D investment in 2011

Code: E04131201

04-12-2012

Synta, MMRC announce clinical trial for Hsp90 inhibitor

Code: E04121200

04-11-2012

Takeda to acquire URL Pharma for $800 million

Code: E04111200

April 2012

Online software for RNA FISH probe set design

April 2012

Making genomic research whole

Code: E041225

April 2012

Improved pharmacokinetics in human antibody therapeutics

April 2012

Charles River rolls toward improved viral clearance studies

Code: E041226

April 2012

Clostridia GDH monoclonal antibodies

April 2012

An immunological decision

Code: E041227

April 2012

Sister companies trod biosimilar path

Code: E041228

April 2012

Akorn acquires certain assets of Kilitch Drugs in India

April 2012

Xencor, Boehringer Ingelheim partner on biosuperior antibodies

April 2012

Jubilant announces collaboration with Mnemosyne

April 2012

Quintiles, RVC Biofund team up for Russian clinical expansion

April 2012

Abbott and Merck go FISH

Code: E041213

April 2012

Translating a pilot into a full collaboration

Code: E041214

April 2012

Getting an Angle on cancer

Code: E041215

April 2012

Reinforcing their lines

Code: E041216

04-10-2012

Mylan sues FDA to overturn Teva Pharmaceutical’s exclusivity for Provigil

Code: E04061201

04-10-2012

Optimer Pharmaceuticals shakes up leadership spots

Code: E04091201

04-10-2012

Affymax gets $50 million milestone in anemia deal with Takeda

Code: E04101201

04-10-2012

Do the winds favor Illumina in face-off with Roche?

Code: E04111201

04-10-2012

Amgen to pay $315 million for KAI Pharmaceuticals

Code: E04111202

04-10-2012

Sanford-Burnham researchers identify key functions of immune system response

Code: E04111203

04-10-2012

Mount Sinai School of Medicine identifies protein kinase that plays a significant role in kidney fibrosis

Code: E04111204

April 2012

Everything old is new again

Code: E041230

April 2012

Great minds think alike

Code: E041229

April 2012

Biodesix in Phase III trial collaboration with Kadmon

April 2012

OGI invests in Rna Diagnostics

April 2012

NextGen finalizes diagnostics subsidiary

April 2012

Personalized medicine market exceeds $28 billion

April 2012

Hot target for HCV

Code: E041206

April 2012

Jumping on JAK1

Code: E041205

April 2012

Antibody potential a 'SIMPLE' fact

Code: E041207

April 2012

Coming into the light

Code: E041208

April 2012

Medicago and Mitsubishi Tanabe Pharma in vaccines deal

April 2012

University of Dundee granted $15.7 million from Wellcome Trust

April 2012

Medicyte, PRIMACYT to develop hepatocytes

April 2012

GDBP gains license to monoclonal antibody for China

April 2012

Acquiring a peer across the Atlantic

Code: E041217

April 2012

Sanofi cultivates 'research ecosystem'

Code: E041218

April 2012

Delivering genomics to routine care

Code: E041219

April 2012

Ready and aiming

Code: E041220

April 2012

MJFF showcases Parkinson’s disease advances by Kinemed

April 2012

NWO to fund proteomics research facility

April 2012

Clinical Genomics Center established by Lab21, ITOR

April 2012

Pfenex, DNA2.0 establish research collaboration

April 2012

Service expansion provides European availability

April 2012

Endogenous histone modulation kits offer simplicity

April 2012

96-channel pipetting for multiple modes

April 2012

Polymeric SPE cartridges, well plates for solid-extraction treatment

April 2012

Power supply for multiple gel electrophoresis runs

April 2012

Workflow and documentation solution for linking information systems

April 2012

Fully configurable web-based randomization system

April 2012

Low-volume flow calorimeter offers label-free sample monitoring

April 2012

Space conservation, easy transport with rolling centrifuge cabinet

April 2012

Hands-free bar code reading

April 2012

Significant time savings for digital titration

April 2012

European services expanded to include sample preparation

April 2012

DNA monitoring in therapeutic proteins and monoclonal antibodies

April 2012

Label-free LC-MS data analysis

April 2012

Microplate multimode reader features sensitivity, robustness

April 2012

3D cell culture via magnetic levitation

April 2012

Benchtop DNA sample concentrator

April 2012

Biomolecular quantitation system

April 2012

Multiplex immunoassays for Th17 cytokine and cancer biomarkers

April 2012

Combined supercritical fluid chromatography and ultra high-performance liquid chromatography

April 2012

Current-clamp upgrade kit for cardiac and neuronal cell excitability analysis

April 2012

A biopharmaceutical bonanza

Code: E041209

April 2012

Across all domains

Code: E041210

April 2012

A rock-solid partnership

Code: E041211

April 2012

Comparing apples to Apples

Code: E041212

April 2012

TIBCO, ChemAxon integrate analytics data management applications

April 2012

Stem cells focus of EMD Millipore, CCRM alliance

April 2012

Lucigen receives $2.5 million grant from NIH

April 2012

Wellspring, CTSA-IP aim to foster public-private partnerships

April 2012

Being flexible with Fleximer

Code: E041221

April 2012

Code: E041222

April 2012

Joined together by JNK

Code: E041223

April 2012

Crossing the 'Valley of Death'

Code: E041224

April 2012

University of Pittsburgh and UPMC partner with J&J corporate office

April 2012

License agreement centered on ulcerative colitis compound

April 2012

Islet Sciences acquires DiaKine, gains diabetes therapeutic

April 2012

ACADIA, Allergan extend ophthalmic collaboration

April 2012

Chromatography media for high-purity separation

April 2012

Monoclonal antibodies for Herceptin recognition

April 2012

Percentage carbon, hydrogen, nitrogen determination

April 2012

Animal transfer station minimizes allergens, contamination

April 2012

Monoclonal antibodies for IHC, immunoassay analysis

April 2012

Pharma pink-slippers find pot of gold

Code: E041201

April 2012

A new sun rises for vaccines

Code: E041202

April 2012

Bridge over the Charles River

Code: E041203

April 2012

BGI on board with ‘Novo Nordisk Way’

Code: E041204

April 2012

Completing the picture with regulatory information management

April 2012

Taking inventory of life-science headcounts

April 2012

The little biotech that could

04-05-2012

Roche: Illumina's fiduciary duties 'require engagement'

Code: E04041201

04-05-2012

Spectrum Pharmaceuticals to acquire Allos Therapeutics

Code: E04041202

04-03-2012

AstraZeneca, Amgen partner on monoclonal antibodies

Code: E04031201

04-02-2012

Forest Laboratories buys blood pressure drug Bystolic from Janssen Pharmaceutica for $357 million

Code: E04021201

04-02-2012

New Genentech breast cancer drug shows late stage trial success

Code: E03301201

03-29-2012

Roche increases offer price to approximately $6.7 billion

Code: E03291201

03-27-2012

Roche extends hostile acquisition offer yet again, Illumina continues to resist

Code: E03281201

03-27-2012

Shire to acquire FerroKin BioSciences for as much as $325 million

Code: E03281202

03-27-2012

UC Davis probes smoke exposure’s role in development of COPD

Code: E03281203

03-27-2012

Derailing diabetes

Code: E03281204

03-27-2012

Seeing eye to eye

Code: E03271201

03-26-2012

U.S. court dismisses AstraZeneca lawsuit against FDA

Code: E03261201

03-26-2012

Amylin and Lilly gets thumbs-up from European Union for new Byetta use

Code: E03231201

03-22-2012

New Index Ventures fund to support life sciences companies

Code: E03211201

03-22-2012

MSKCC, IBM partner on decision support system

Code: E03221201

03-20-2012

Roche files definitive proxy, sends letter to Illumina shareholders

Code: E03201201

03-20-2012

UCB, Oxford join forces in research collaboration

Code: E03201202

03-19-2012

Illumina continues to resist Roche takeover

Code: E03191201

03-16-2012

Shire to acquire FerroKin BioSciences for as much as $325 million

Code: E03161201

03-15-2012

Aeras granted $220 million from Gates Foundation

Code: E03151201

03-14-2012

Marina, ProNAi partner in exclusive license agreement

Code: E03141201

March 2012

Addtech adds one

Code: E031209

March 2012

Speaking the right language

Code: E031210

March 2012

A hot microplate

Code: E0031211

March 2012

Building on their relationship

Code: E031212

March 2012

Pistoia Alliance partners with Eagle Genomics, Cycle Computing

March 2012

Tecan, Waters join up in OEM agreement

March 2012

Sartorius Stedim, Refine to develop cultivation platform

March 2012

New collaboration to validate diabetic nephropathy biomarkers

March 2012

Homing in on hematology

Code: E031221

March 2012

Cytomedix undergoes business regeneration

Code: E031222

March 2012

Engendering the collaborative spirit to cure MS

Code: E031223

March 2012

Puff the magic drug-delivery system

Code: E031224

March 2012

IMUC, University of Pa. in deal for dendritic-cell production technology

March 2012

Covance, BioPontis announce drug development agreement

March 2012

TB targeted in ICB&DD, Sanofi collaboration

March 2012

Zalicus, Hydra partner on ion channel modulators

03-13-2012

AstraZeneca files lawsuit against FDA to delay generic competition

Code: E03141201

03-13-2012

Busy times for Pfizer

Code: E03141202

03-13-2012

HIV roadblock in HD

Code: E03141203

03-13-2012

Melanoma therapy resistance mechanism identified in Sanford-Burnham study

Code: E03141204

03-13-2012

Domain Therapeutics granted EUR 933,000 for schizophrenia work

Code: E03131200

03-12-2012

Bowel drug being studied by Tranzyme and Norgine fails to make the grade

Code: E03121201

03-12-2012

Another step toward an HIV cure

Code: E03091201

March 2012

Picking up a Chip

Code: E031213

March 2012

Trovagene closes on CLIA

Code: E031214

March 2012

New companions for new tests

Code: E031215

March 2012

Code: E031216

March 2012

A*STAR, GE Global Research in medical imaging deal

March 2012

Ventana, Bayer collaborate on ADC diagnostic test

March 2012

Microbiology detection focus of new SDIX, BD agreement

March 2012

Horizon Diagnostics, UK NEQAS announce strategic partnership

March 2012

FDA provides guidance on biosimilars

Code: E031225

March 2012

Privacy vs. right to know

Code: E031226

March 2012

Code: E031227

March 2012

SPRINTing to a cure

Code: E031228

March 2012

AACR Annual Meeting 2012: Photos and Other Additional Material

Code: E031299

March 2012

NIH facing flat budget in FY 2013

March 2012

Comment period reopened for advertising rule

March 2012

Biomedical momentum wanes in California

March 2012

A deal with first-in-class cancer potential

Code: E031205

March 2012

The power of partnering

Code: E031206

March 2012

A breath of fresh air

Code: E031207

March 2012

Code: E031208

March 2012

Fluidigm, AH diagnostics sign Scandinavian distribution deal

March 2012

McMaster receives $30 million for stem cell facility

March 2012

Agios, iNovacia announce new collaboration

March 2012

Abbott, DNDi sign NTD research agreement

March 2012

Genentech reaches for the stars

Code: E031217

March 2012

Doing the monogenic mambo

Code: E031218

March 2012

Spanish partners to develop low-cost informatics methods for clinical genomics

Code: E031219

March 2012

Code: E031220

March 2012

KineMed and Pfizer to advance novel approaches in metabolic disease

March 2012

Alnylam identifies new method to monitor RNAi activity

March 2012

Medicinal Genomics acquired by Courtagen

March 2012

DNA, RNA extraction kits focus of OEM agreement

March 2012

FFPE solutions for high-quality genetic and genomic data

March 2012

Anti-GFP antibodies for multiple research purposes

March 2012

Probe sets for RNA quantification

March 2012

Tumor cell line panels for targeted research ATCC

March 2012

Versatile panels for cancer research analytes

March 2012

Co-cultured in-vitro angiogenesis assay kit

March 2012

Kit for measurement of glycolytic activity in cells

March 2012

Modular biobanking at -80°C

March 2012

Label printing in 200 or 300 dpi

March 2012

Accurate data display for cancer research

March 2012

Anayltical instrument qualification software offers streamlined, digital process

March 2012

Dedicated service for identification, analysis in rare disease research

March 2012

Bead mill homogenizer with horizontal tube positioning

March 2012

Software upgrade features for enhanced image data storage and analysis

March 2012

New range of affinity columns for process monitoring

March 2012

Microbial colony pickers series offers 98-percent efficiency

March 2012

High-throughput library prep solution offers greater speed, sample reproducibility

March 2012

Precast gels enable protein separation, gel imaging, data analysis in 20 minutes

March 2012

Label-free cellular profiling service for increased productivity

March 2012

Advanced microplate washer with touchscreen user interface

March 2012

Acoustically compatible microplates for reagent libraries

March 2012

Automated buffer preparation for bioprocessing

March 2012

Powerful new LIMS aids paperless work environments

March 2012

qPCR primers for use with intercalating dyes

March 2012

Automated solution for DNA sample enrichments

March 2012

Water purification systems for Type 2 pure water needs

March 2012

Cartridges feature chromatographically tested propriety silica

March 2012

Screening kits for DNA damage research

March 2012

Objective lens allows for imaging to depth of 5.6 mm in brain tissue

March 2012

New electrophoresis instrumentation for varied analyses

March 2012

Just a shot in the dark?

Code: E031230

March 2012

Amgen takes a big BiTE

Code: E031201

March 2012

Playing hard to get

Code: E031202

March 2012

Oceania-bound and generic-focused

Code: E031203

March 2012

Sunshine State collaboration

Code: E031204

March 2012

Guest Commentary: So you want to collaborate?

March 2012

Out of Order: Watch that last step

March 2012

Falling short of filling unmet medical needs

03-09-2012

Promedior raises $21.5 million for fibrotic therapeutics

Code: E03081201

03-08-2012

Mersana, Endo to collaborate on ADC development

Code: E03071201

03-07-2012

Medicago, MTPC join forces in vaccine agreement

Code: E03061201

03-05-2012

Merck: Good news, bad news

Code: E03051201

03-05-2012

An end to the Farbrazyme shortage?

Code: E03021201

03-01-2012

Boston Biomedical Inc. to be acquired by DSP

Code: E03011201

02-29-2012

Enrollment completed for Phase III trial of GI motility drug

Code: E02291201

02-28-2012

Roche-Illumina saga continues with offer extension

Code: E02281201

March 2012

AACR Annual Meeting 2012: Concentrated delivery

Code: E031229

02-27-2012

Procter & Gamble to cut 5,700 jobs and $10 billion

Code: E02241201

02-27-2012

Angiochem teams with GSK to discover and develop treatments of lysosomal storage diseases

Code: E02271201

02-23-2012

Collegium raises $22.5 million for chronic pain drug

Code: E02221200

02-23-2012

Genomma announces $834 million proposal to acquire Prestige

Code: E02231201

02-21-2012

Corralling Cushing's syndrome

Code: E02211200

02-20-2012

Gilead suffers setback with promising hepatitis C therapy

Code: E02201201

02-20-2012

Biogen Idec to acquire Stromedix in deal worth potentially more than $560 million

Code: E02221201

02-20-2012

PerkinElmer announces collaboration with Rutgers University

Code: E02221202

02-20-2012

Kids on the brain

Code: E02221203

02-20-2012

A mouse that roars against pediatric brain cancer

Code: E02221204

02-17-2012

NYGC initiative with Feinstein Institute to target Alzheimer's

Code: E02161201

02-16-2012

Celladon raises $43 million for heart failure treatment

Code: E02151201

02-14-2012

Biogen Idec acquires Stromedix for $75 million

Code: E02141201

02-13-2012

Valeant continues acquisition spree with agreement to snap up Eyetech Inc.

Code: E02131201

February 2012

Forma Therapeutics in cancer alliance with Janssen Biotech

February 2012

Receptos, Ono to collaborate on GPCR target

February 2012

Marina Biotech, Mirna ink license agreement

February 2012

Mutated gene found in several cancer types

February 2012

OPKO Health acquires FineTech Pharmaceutical

Code: E021213

February 2012

Making their Metamark

Code: E021214

February 2012

Lining up with Lineagen

Code: E021215

February 2012

Getting renal with oncology markers

Code: E021216

February 2012

Xenon, Genentech partner on companion Dx for pain

February 2012

BioTime, USCN sign option, distribution agreements

February 2012

HistoRx licenses diagnostic assay from Yale

February 2012

Arrayit spins off Arrayit Diagnostics to shareholders

February 2012

A leg up for oncology

Code: E021205

February 2012

China experiences diabetes epidemic

Code: E021206

February 2012

A trio of leads for a hopeful future

Code: E021207

February 2012

The role of CD40L in ALS

Code: E021208

February 2012

NovAliX in multi-target drug discovery deal with Teijin Pharma

February 2012

Acino, Teva acquire select Mepha businesses

February 2012

Prestige acquires 17 OTC brands from GSK

February 2012

ChemRar, Agenus ink cancer vaccine agreement

02-10-2012

FDA and HIV: A warning and a rejection this week

Code: E02101201

02-09-2012

Cytomedix snags Aldagen for $16 million in stock

Code: E02081200

February 2012

AZ pursues targeted cancer therapy

Code: E021225

February 2012

Getting to know the locals

Code: E021226

February 2012

Healthymagination alliance

Code: E021227

February 2012

Biologics down under

Code: E021228

February 2012

MonoSol Rx and Midatech launch joint venture

February 2012

Clinigene, Pacific Biomarkers form research agreement

February 2012

ShangPharma opens new facility, extends Lilly contract

February 2012

Tigermed named Medidata Services Partner

02-09-2012

Celgene to invest $15 million in Acetylon

Code: E02091201

February 2012

No inhibitions about drug discovery

Code: E021217

February 2012

Arecor adds Lilly

Code: E021218

February 2012

(Anti)sense and sensibility

Code: E021219

February 2012

Gene therapy at UCL, St. Jude’s infuses hemophiliacs with hope

Code: E021220

February 2012

BMS and Gladstone combat Alzheimer’s disease ‘tsunami’

Code: E021221

February 2012

Follow the leaders

Code: E021222

February 2012

Betting on biosimilars

Code: E021223

February 2012

ADC from A to Z

Code: E021224

February 2012

Sigma-Aldrich looks to buy BioReliance Corp. for $350 million in cash

February 2012

Dynavax, AstraZeneca to move TLR-9 into toxicology studies

February 2012

Merck secures license for Exelixis’ PI3K-delta program

February 2012

Researchers prove iPS cells capable of mirroring disease

February 2012

Adding to Pall’s appeal

Code: E021209

February 2012

Accelrys on a quest

Code: E021210

February 2012

Data warehouse for translational research

Code: E021211

February 2012

A wish to advance ISH

February 2012

UCSD uses RainDance technology for solid-tumor detection

February 2012

Patcore announces Eisai global software license

February 2012

NCGR named Certified Service Provider by Agilent

February 2012

Cresset, Optibrium to collaborate on next-gen platforms

February 2012

PPC technique for ionic current measurements in cell populations

February 2012

Condenser, evaporator combination for lyophilization

February 2012

Gene exploration tool for advanced protein, gene information

February 2012

New IDL specification for GC/MS/MS system

February 2012

Enhanced flow cytometry software

February 2012

Solid-phase extraction cartridges and plates

February 2012

Increased imaging capabilities with confocal technology

February 2012

Bulk reagent dispensing, multichannel pipetting, microplate washing in single system

February 2012

PCR microplates for 96- and 384-well block PCR, sequencing instruments

February 2012

Rapid moisture content analysis

February 2012

Multiple incubator capacities and volumes

February 2012

Improved data quality for polyhistidine-tagged targets

February 2012

Full-genome sequencing in 24 hours

February 2012

Next-generation solutions for guided treatment decision support

February 2012

Plate-based data analysis and management for HCS

February 2012

Low-noise, low-energy PCR instrumentation

February 2012

Automation for liquid sampling process

February 2012

Procoagulant and microparticle measurement products

February 2012

Versatility and precision in microscope automation system

February 2012

Trio of NGS library preparation modules

February 2012

Automated sample prep platform with compact footprint

February 2012

Sequencing system offers capabilities in a range of applications

February 2012

Ultra-low temperature storage for samples down to -85˚C

February 2012

Trio of freezer sizes for upright storage

February 2012

Transfection reagent for large-scale production

February 2012

Multiple illumination options available with gel imaging system

February 2012

Ultraviolet crosslinker offers faster, more accurate analysis

February 2012

NGS data analysis software offers multiple methods, analyses

02-07-2012

ADC from A to Z

Code: E02081201

02-07-2012

Eli Lilly and Co. plans to freeze salaries for most employees in 2012

Code: E02081202

02-07-2012

Cancer Research UK scientists ‘bag up and bin’ weak spot in cancer cells

Code: E02081203

02-07-2012

Scripps researchers aim for a triple

Code: E02081204

02-07-2012

Illumina rejects Roche proposal, decries offer as 'grossly inadequate'

Code: E02071200

February 2012

A perfect match

Code: E021229

February 2012

Seeking a rare and precious prize

Code: E021201

February 2012

Abbott and Reata AIM high

Code: E021204

February 2012

Pfizer, Karo Bio go nuclear

Code: E021203

February 2012

CROs form Asia Alliance

Code: E021204

February 2012

Pay for delay: Right or wrong?

February 2012

Stuck between evidence and policy

February 2012

Leave Paula Deen alone, y’all

02-05-2012

Merck KGaA signs cancer deal with Threshold Pharmaceuticals

Code: E02031201

02-02-2012

7,300 face layoffs as AstraZeneca announces restructuring program

Code: E02021201

02-01-2012

Roche prepares slate of board candidates for Illumina’s annual meeting

Code: E02011201

02-01-2012

ZFP technology forms basis of $13 million Sangamo, Shire agreement

Code: E02011202

01-31-2012

Organizations form global partnership to battle NTDs

Code: E01311201

01-30-2012

Valeant abandons effort to acquire ISTA

Code: E01301201

01-27-2012

Up and down: The A's and B's of staffing

Code: E01271201

01-27-2012

Round three ensues in hostile takeover attempt of Illumina by Roche

Code: E01271202

01-26-2012

Illumina announces stockholder rights agreement in wake of Roche proposal

Code: E01261201

01-25-2012

Roche tenders unsolicited $5.7 billion acquisition proposal for Illumina

Code: E01251200

01-24-2012

First studies in Pediatric Cancer Genome Project identify genetic changes in leukemia, retinoblastoma

Code: E01251203

01-24-2012

Going public: FNIH Biomarkers Consortium to release Alzheimer’s biomarker data

Code: E01251204

01-24-2012

ddn Cancer Research Portal Exclusive: Adjuvants--The Heroes of Immunotherapy

01-24-2012

Watson Pharmaceuticals buys Ascent Pharmahealth Ltd. for $393 million

Code: E01251202

01-24-2012

EMD Millipore, Proteomics International to collaborate on diabetic nephropathy biomarkers

Code: E01241201

01-23-2012

Alnylam to slash workforce by a third

Code: E01201201

01-23-2012

Roche sets up co -marketing agreement with Unlibabs for greater access to HPV tests

Code: E01231201

01-23-2012

Lab21 acquires new real-time PCR technology

Code: E01231202

01-19-2012

Ventana lines up third recent companion diagnostic agreement

Code: E01191201

01-18-2012

Takeda announces workforce reductions of 2,800

Code: E01181201

01-17-2012

Epigenetics form epicenter of Genentech, Constellation agreement

Code: E01171201

01-17-2012

Novartis to restructure U.S. business and cut more than 1,900 jobs

Code: E011712

January 2012

Growth in India

Code: E011209

January 2012

Corning Life Sciences acquires Mediatech

Code: E011210

January 2012

Shopping for companies during the holidays

Code: E011211

January 2012

An unfolding development

Code: E011212

January 2012

Reinnervate and Mirus Bio launch 3D transfection system

January 2012

Fluxion Biosciences to distribute Millipore’s PrecisION ion channel cell lines

January 2012

Horizon Discovery to collaborate with NCI, NHGRI

01-12-2012

NantWorks to acquire, redevelop former Indiana Pfizer plant

Code: E011201

01-11-2012

FORMA forms new oncology collaborations

Code: E01111200

January 2012

A positive outcome for breast cancer patients

Code: E011221

January 2012

Hands across Kendall Square

Code: E011222

January 2012

The power of three

Code: E011223

January 2012

Waste not, want not

Code: E011224

January 2012

BMS, Tibotec to target HCV

January 2012

MacroGenics, Servier announce license agreement

January 2012

Stem cell research leaders NYSCF, HSCI join forces

January 2012

High-end multimode microplate reader

January 2012

Microplate washer with touch screen

January 2012

Multichannel pipettes offer increased throughput capabilities

January 2012

Cardiomyocytes for predictive toxicity testing

January 2012

Multiplex assays for cellular metabolism research

January 2012

IEF system independently powers each lane

January 2012

Ultra-low temperature freezers maximize sample storage capacity, minimize energy usage

January 2012

Pipette tips provide access to samples in deep and narrow labware

January 2012

Changing the channel

Code: E011217

January 2012

System enables cell transfection in 3D culture

January 2012

An alternative to whole-genome sequencing

Code: E011218

January 2012

SPE extraction system automates tedious manual cartridge-based methods

January 2012

New histology lineup addresses inconsistent preparation of samples in biomedical research and diagnostics

January 2012

Going commercial

Code: E011219

January 2012

Novel library concept results in drug candidates with superior properties

January 2012

Microvolume, label-free analysis platform for personal assays

January 2012

384-well, clear-bottom microplates facilitate automation compatibility

January 2012

Bruker goes to Korea

Code: E011220

January 2012

Cell imaging station enables fast verification of labeled cells

January 2012

Multimode plate reader offers versatility, reliability and sensitivity

January 2012

Cellectis-Novartis technology to introduce new characteristics into genomes

January 2012

Momenta secures Virdante assets for $4.5 million

January 2012

NINR earmarks $2 million for chronic wound research

January 2012

Meeting the need for speed

Code: E011225

January 2012

A high-stakes dispute

Code: E011226

January 2012

Genetic testing garners lawmaker’s attention

Code: E011227

January 2012

FDA revokes Avastin breast cancer approval

January 2012

Pfizer bribery settlement to exceed $60 million

January 2012

Documents demanded on Pfizer’s Lipitor deals

January 2012

Good cop, bad cop, market share

Code: E011205

January 2012

A ‘win, win, win’ for public-private partners

Code: E011206

January 2012

The appeal of zeal

Code: E011207

January 2012

The eyes have it

Code: E011208

January 2012

Merck announces Chinese R&D facility

January 2012

Shire, Shionogi partner on ADHD medicines

January 2012

GVK Biosciences in multi-year collaboration deal with Moulder Center

January 2012

Roadmap to theranostics

Code: E011213

January 2012

Deal aggressively targets oncology Dx

Code: E011214

January 2012

MDxHealth, Celldex ink deal for brain cancer test

Code: E011215

January 2012

Trauma on their minds, treatment in their thoughts

Code: E011216

January 2012

Ezose aligns with Shionogi’s Diagnostics division

January 2012

Protagen and Bayer collaborate on diagnostic biomarkers for endometriosis

January 2012

SuperNova Diagnostics partners with Concile

01-10-2012

Janssen Pharmaceutica and Proteros expand relationship and enter into global agreement

Code: E01091201

01-10-2012

Plasticell to join Pfizer and University of Sheffield in a stem cell project led by Cellzome

Code: E01101201

01-10-2012

Bristol-Myers Squibb to acquire Inhibitex for $2.5 billion

Code: E01111201

01-10-2012

Sigma-Aldrich looks to buy BioReliance Corp. for $350 million in cash

Code: E01111202

01-10-2012

Don’t stress out

Code: E01111203

01-10-2012

MIT researchers show how flu viruses mutate

Code: E01111204

January 2012

Rebooted and upgraded - SLAS2012 Show Preview

Code: E011228

January 2012

The social side of SLAS2012

01-09-2012

BDSI, Endo announce license agreement for pain treatment

Code: E01051201

January 2012

Curing from hand to mouth

Code: E011201

January 2012

Growing steadily downstream

Code: E011202

January 2012

‘The next big thing is already here’

Code: E011203

January 2012

Genes that fit everyone

Code: E011204

January 2012

Examining recent approaches to treating solid tumors

January 2012

Out of Order: Gift horses

January 2012

Keeping our resolution to report the news

01-04-2012

Biogen Idec, Isis announce SMA collaboration

Code: E01041201

01-03-2012

Are schizophrenia sufferers 'too tightly wound' genetically?

Code: E01031200

01-03-2012

Accelrys nabs VelQuest for $35 million, strengthens paperless offerings

Code: E01031201

12-30-2011

Alexion to pay as much as $1 billion for Enobia

Code: E12291101

12-28-2011

Neuralstem secures FDA approval for Phase Ib MDD trial

Code: E12281101

12-28-2011

Zogenix, Astellas end co-promotion agreement early

Code: E12281102

12-26-2011

IBM makes massive research data available to public

Code: E12281101

12-26-2011

Pall aims for ForteBio to extend capabilities in $1B+ biopharma process monitoring market

Code: E12281102

12-26-2011

MIT researchers link sirtuins to anxiety and mood control

Code: E12281103

12-26-2011

Making the best of a sticky situation

Code: E12281104

12-22-2011

Takeda to acquire Intellikine for $190 million

Code: E12211101

12-22-2011

Merck licenses PI3K-delta inhibitor from Exelixis

Code: E12221101

12-20-2011

Amgen, Watson partner on (bio)similar interests

Code: E12201101

12-19-2011

Burrill & Co. launches life sciences venture fund with $313 million in commitments

Code: E12191101

12-19-2011

Pall Corp. to acquire ForteBio

Code: E12191102

12-18-2011

Valeant launches $327 million hostile bid for ISTA Pharmaceuticals

Code: E12161101

12-15-2011

Fanning the 'Embers' in metabolic research

Code: E12151101

12-14-2011

TGen, Karmanos to lead three-year melanoma study

Code: E12141100

12-13-2011

Abbott and Reata announce deal to develop and commercialize next-gen antioxidant inflammation modulators

Code: E12121101

12-13-2011

Geron abandons stem cell work and shifts to oncology focus

Code: E12141101

12-13-2011

Elsevier acquires Ariadne Genomics

Code: E12141102

12-13-2011

Researchers identify structure of Ebola virus-neutralizing antibody

Code: E12141103

12-13-2011

‘Homing’ in on side effect-free therapies

Code: E12141104

12-13-2011

ddn announces 2011 iPad contest winner

Code: E12131101

12-13-2011

ImmusanT nets $20 million for treatment, diagnostic for celiac disease

Code: E12131102

December 2011

The personal side of cell biology

Code: E121129

12-08-2011

AstraZeneca acquires BeiKang Pharmaceutical Company Ltd.

Code: E12081101

12-07-2011

Theratechnologies to cut COPD program, 40 jobs

Code: E12071101

December 2011

Taking a new pathway

Code: E121109

December 2011

Going 'Broad' to get specific about cancer

Code: E121110

December 2011

One assay, 242 genes

Code: E121111

December 2011

Finding satisfaction in stratification

Code: E121112

December 2011

Agilent, Ambry Genetics announce SureSelect agreement

December 2011

EMD Millipore to distribute HepaRG cells from Biopredic

December 2011

Mystaire acquires product division from Misonix

December 2011

A high-'Profile' partnership

Code: E121117

December 2011

A gram better way to do things

Code: E121118

December 2011

Start spreading the news

Code: E121119

December 2011

Adding tools to the toolbox

Code: E121120

December 2011

Quanticel, Celgene announce strategic collaboration

December 2011

Duke wins $25 million NINDS grant

December 2011

Potential new sickle-cell treatment discovered

December 2011

Making a spark, igniting a fire

Code: E121121

December 2011

Two heads are better than one

Code: E121122

December 2011

Another brick in the wall

Code: E121123

December 2011

Done deal times two

Code: E121124

December 2011

BMS, Gilead to develop combination HIV pill

December 2011

Taconic to partner with Oncodesign on oncology imaging

December 2011

Athersys, Fast Forward to collaborate on MS treatment

12-06-2011

Building on biosimilars

Code: E12061101

December 2011

Plug-and-play deal

Code: E121101

December 2011

Doing some corporate stock-up shopping

Code: E121102

December 2011

Getting to the heart of the matter

Code: E121103

December 2011

Being 'companionable' with new immunotherapy

Code: E121113

December 2011

Taking direct action

Code: E121104

December 2011

A full work-up for Alzheimer’s disease

Code: E121114

December 2011

Pancreatic cancer biomarkers sought

Code: E121115

December 2011

Your halo is showing

Code: E121116

December 2011

Labcyte receives funding from NCI for biomarker validation program

December 2011

NCI awards $2.3 million to ImaginAb

December 2011

PrognosDx Health, Accium announce research agreement

December 2011

Data management that speeds—rather than impedes—advanced DNA sequencing applications

December 2011

On biobanking: Deposits and withdrawals

December 2011

Bomb meets bomber in new deal

Code: E121105

December 2011

Cancer deaths in Korea

Code: E121106

December 2011

Not ‘immune’ to each other’s charm

Code: E121107

December 2011

Out with the old, in with many new features to ddn

December 2011

Two against the flu

Code: E121108

December 2011

Ipsen sells North American rights for Apokyn

December 2011

Hawaii Biotech reacquires vaccine technology licenses from Merck

December 2011

ProBioGen, Inhibrx ink license agreement

December 2011

WuXi buys in its backyard

Code: E121125

December 2011

Injecting strength into the business

Code: E121126

December 2011

Repligen acquires Novozymes Biopharma

Code: E121127

December 2011

Design, make, test

Code: E121128

December 2011

Charles River, Protagen ink alliance

December 2011

Cobra Biologics announces Unitech Pharma Group acquisition

December 2011

ViiV announces Russian manufacturing

December 2011

Real-time PCR instruments perform in small benchtop footprint

December 2011

Affordable, high-performance kit enables high-yield enzymatic cleanup of PCR products

December 2011

Single-cell, high seal resistance plates provide flexibility for kinetic studies, demanding applications

December 2011

Data acquisition and analysis software with new data analysis, reporting features

December 2011

LED light transilluminator features highly sensitive imaging of fluorescent dyes

December 2011

Spectrometer combines accuracy, sensitivity in small, robust instrument

December 2011

Service enables researchers to order ready-for-use oligos in a quick, easy manner

December 2011

Multidetection microplate reader for high-throughput screening

December 2011

Pipette tips optimize large-volume transfers

December 2011

Complete case management solution for digital pathology

December 2011

Heating and chilling laboratory equipment

December 2011

Fully automated colony isolation system

December 2011

Software for flexible syringe pump control

December 2011

Core-shell HPLC/UHPLC technology for proteins and peptides

December 2011

Isoelectric focusing system powers each lane for uncompromised results

December 2011

Protein A media boosts productivity in monoclonal and polyclonal antibody capture, lowers costs

December 2011

Automated recombinant protein synthesis/purification system

December 2011

Condenser enhances lyophilization results

December 2011

Extract answers from analytical data

December 2011

Competitive intelligence solution for the pharmaceutical industry

December 2011

Bath-free dissolution apparatus for testing release rate of pharmaceutical products

December 2011

Microbiological testing funnel ensures sterility

December 2011

High-throughput kit features increased barcoding options

December 2011

Protein production data management platform

12-01-2011

MacroGenics, Servier announce a 'solid' agreement

Code: E12011101

11-30-2011

Affymetrix nabs eBioscience for $330 million

Code: E11301101

11-29-2011

Abbott expands companion Dx agreement with GSK to add test for additional investigational cancer immunotherapy antigen

Code: E11281101

11-29-2011

QIAGEN launches restructuring plan; 8% to 10% of workforce faces chopping block

Code: E11291102

11-29-2011

Roche to team up with PTC Therapeutics

Code: E11291101

11-22-2011

Valeant nabs iNova for approximately $689 million

Code: E11221101

11-21-2011

Geron discontinues stem cell work to focus on oncology

Code: E11231101

11-21-2011

Leica Microsystems acquires Labindia’s microscopy and histopathology divisions

Code: E11231102

11-21-2011

New cancer therapy helps tumors "go to the light"

Code: E11231103

11-21-2011

MSKCC researchers use hESCs to treat Parkinson’s disease in animal models

Code: E11231104

11-21-2011

Gilead to acquire Pharmasset for $11 billion

Code: E11211101

11-18-2011

CureVac announces set of agreements with Sanofi Pasteur

Code: E11171101

11-18-2011

Medicis makes successful bid for Graceway assets

Code: E11181101

11-16-2011

ViroPharma completes DuoCort acquisition

Code: E11161101

11-15-2011

Geron announces end of stem cell programs

Code: E11151101

11-14-2011

FEI makes strategic life sciences tech acquisition by buying TILL Photonics

Code: E11141101

11-11-2011

Signum Biosciences, GSK announce collaboration

Code: E11111101

11-11-2011

Children’s Hospital Boston, Pfizer announce DMD agreement

Code: E11111102

11-09-2011

Teva to make up to 1,500 additional job cuts

Code: E11091101

11-08-2011

Pharmasset share price gets a boost after 100-percent cure rate in HCV trial

Code: E11091101

11-08-2011

NanoString nabs $20 million in a Series D round involving GE and former Genzyme CEO

Code: E11091102

11-08-2011

BWH researchers ‘unlock’ key to targeting stem cells to specific tissues

Code: E11091103

11-08-2011

Dana-Farber Cancer Institute and Brigham and Women's Hospital launch massive cancer study

Code: E11091104

November 2011

Nigel's new ark

Code: E111118

November 2011

One-stop shopping for microbial genomes

Code: E111119

November 2011

Of mice and men

Code: E111120

November 2011

Code: E111121

November 2011

BGI unveils monkey exome sequencing platform

November 2011

Researchers identify new diabetes-related gene

November 2011

The Jackson Laboratory gains $25.1 million grant from NIH

November 2011

Puma roars with Pfizer licensing deal

Code: E111122

November 2011

Adding a jewel to the crown

Code: E111123

November 2011

Taking down a triple threat with Karmanos and Komen

Code: E111124

November 2011

Art and nature at high altitude

Code: E111131

November 2011

Vanderbilt forges path for academia

Code: E111125

November 2011

Stem cells get specific

Code: E111126

November 2011

Silicon, Fox Chase unite in technology agreement

November 2011

Millennium joins MMRF in personalized medicine initiative

November 2011

Boehringer Ingelheim, Gilead ink HIV license agreement

November 2011

A mile-high view

Code: E111130

November 2011

Trends in Cell Biology: ddn Interview with Dr. V. Jo Davisson

Code: E111133

11-08-2011

Amylin, Lilly terminate diabetes alliance

Code: E11081101

November 2011

Exonhit, Pfizer collaborate on Alzheimer’s biomarkers

Code: E111114

November 2011

Quantum Materials and Nanoaxis announce tech alliance

Code: E111115

November 2011

Hope for the ‘Worried Man Blues’

Code: E111116

November 2011

Making an overseas connection

Code: E111117

November 2011

BMS, Saladax expand diagnostics collaboration

November 2011

RedHill, UCF announce license deal

November 2011

The Biotrin Group opens new Dublin facility

11-04-2011

GSK reaches investigation agreement with U.S. government

Code: E11041101

November 2011

Seeking a silver lining

Code: E111110

November 2011

Code: E111111

November 2011

Sony tunes in to microfluidics

Code: E111101

November 2011

BMS sees ambiance with Ambrx

Code: E111102

November 2011

If at first you don’t succeed …

Code: E111103

November 2011

Some trick pony

Code: E111104

November 2011

The biorepository: The cornerstone of drug development

November 2011

Removing a pain point

Code: E111112

November 2011

In the EU, stem cells unpatentable if an embryo is destroyed

November 2011

A news story is only as good as its sources

November 2011

Mapping the Scottish genome

Code: E111113

November 2011

Signed, sealed and delivered

Code: E111127

November 2011

IntelliCell, Millipore ink distribution deal

November 2011

Cloud-based research exchange

November 2011

License nets Roche technology from Biodesign Institute, Columbia

November 2011

Phosphorylated histone double-affinity purified H2AX antibody for Western blotting and immunocytochemistry

November 2011

Sapio’s Exemplar LIMS selected by Center for Epigenetics

November 2011

Pre-packaged lentiviral biosensors for real-time visualization of proteins in live cells

November 2011

Container rack for laboratory rockers

November 2011

Small platform supporting state-of-the-art technology for fast PCR protocols

November 2011

Sub-2-micron UHPLC column for reversed-phase protein characterization

November 2011

ELISA kits enable quantitative measurement of autophagy biomarkers without need for expensive equipment, long procedures

November 2011

Microarrays for gene expression analysis of model and applied research organisms

November 2011

Complete and individual control of O2 and CO2 in your microplate reader

November 2011

Additions to personal sequencer system creates intuitive, integrated user experience

November 2011

Enterprise-wide cheminformatics suite

November 2011

Prometheus—unbound or not

Code: E111128

November 2011

FDA, federal agencies team up to develop technologies that predict drug safety

Code: E111129

November 2011

NIH grants $9 million to Medical College researcher

November 2011

NHGRI earmarks $31.5 million for ENCODE

November 2011

Gliknik secures $1.5 million SBIR grant from NCI

November 2011

MS and NSCLC targeted

Code: E111105

November 2011

Going after glycobiology

Code: E111106

November 2011

Catching the pipeline

Code: E111107

November 2011

Serving up with Servier

Code: E111108

November 2011

Looking for a TD on TB

Code: E111109

November 2011

Sanofi Pasteur, UC San Diego target acne treatment

November 2011

Nuevolution, Boehringer Ingelheim form new collaboration

November 2011

Hikma acquires 63.9 percent of Promopharm

11-03-2011

Sanford-Burnham, Pfizer announce partnership

Code: E11021101

11-02-2011

Alnylam, GSK team up in new collaboration

Code: E11021101

11-02-2011

SurModics to offload pharmaceuticals subsidiary to Evonik

Code: E11021102

10-27-2011

Syk inhibitor focus of new Biogen, Portola collaboration

Code: E10271101

10-26-2011

Acton, Sanofi sign license agreement for allergy aerosol

Code: E10261101

10-25-2011

Cubist Pharmaceuticals to buy Adolor Corp. in potential $415 million deal

Code: E10241101

10-25-2011

Abbott does the two-step

Code: E10261101

10-25-2011

Novartis to lay off another 2,000 people

Code: E10261102

10-25-2011

MIT research group uses RNA interference to shut off inflammation

Code: E10261103

10-25-2011

Researchers nail down six genetic variants for diabetes

Code: E10261104

10-25-2011

Amgen announces $780 million charge for claims settlement

Code: E10251101

10-20-2011

Gladstone, Roddenberry Foundation open new stem cell center

Code: E10201101

10-18-2011

Les Laboratories Servier, miRagen sign new agreement

Code: E10181101

10-14-2011

A few hitches 'across the pond' for pharma products

Code: E10141101

10-13-2011

Amarantus closes Equity Funding Facility

Code: E10131101

10-12-2011

Bayer, Onyx Pharmaceuticals restructure Nexavar partnership

Code: E10121101

10-11-2011

FDA approves Merck’s Juvisync, the first combination drug to treat type 2 diabetes and high cholesterol in one tablet

Code: E10121101